Processing 00000000.tx.1: COMMUNICATION: Nontoxic Amyloid Peptide1-42 Suppresses Acetylcholine Synthesis POSSIBLE ROLE IN CHOLINERGIC DYSFUNCTION IN ALZHEIMER'S DISEASE* (Received for publication, July 15,1996, and in revised form, September 23,1996) Minako Hoshi , Akihiko Takashima , Miyuki Murayama , Kaori Yasutake , Natsuko Yoshida , Koichi Ishiguro , Toshimitsu Hoshino and Kazutomo Imahori From the Mitsubishi Kasei Institute of Life Sciences, 11Minamiooya, Machida-shi, Tokyo 194,Japan ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION FOOTNOTES Acknowledgment REFERENCES ABSTRACT We show here that amyloid peptide1-42 (A1-42) may play a key role in the pathogenesis of the cholinergic dysfunction seen in Alzheimer's disease (AD), in addition to its putative role in amyloid plaque formation. 

Phrase: "COMMUNICATION"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0009452:Communication [Social Behavior]

Phrase: ":"

Phrase: "Nontoxic Amyloid Peptide1-42"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1518413:Nontoxic [Qualitative Concept]

Phrase: "Suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "Acetylcholine Synthesis POSSIBLE ROLE IN CHOLINERGIC DYSFUNCTION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "IN ALZHEIMER'S DISEASE"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   913   C0002395:Alzheimer's Disease [Disease or Syndrome]
   913   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "*"

Phrase: "("

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "July 15,"

Phrase: "1996,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "September 23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: "1996"

Phrase: ")"

Phrase: "Minako Hoshi ,"

Phrase: "Akihiko Takashima ,"

Phrase: "Miyuki Murayama ,"

Phrase: "Kaori Yasutake ,"

Phrase: "Natsuko Yoshida ,"

Phrase: "Koichi Ishiguro ,"

Phrase: "Toshimitsu Hoshino"

Phrase: "and"

Phrase: "Kazutomo Imahori From the Mitsubishi Kasei Institute of Life Sciences,"

Phrase: "11Minamiooya,"

Phrase: "Machida-shi,"

Phrase: "Tokyo 194,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040371:Tokyo [Geographic Area]

Phrase: "Japan ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION FOOTNOTES Acknowledgment"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "ABSTRACT"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "We"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "here"

Phrase: "that amyloid peptide1-42"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(A1-42"

Phrase: ")"

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a key role in the pathogenesis of the cholinergic dysfunction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0035820:Role [Social Behavior]
   739   C1705810:Role [Conceptual Entity]

Phrase: "seen in Alzheimer's disease"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0205397:Seen [Qualitative Concept]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "(AD"

Phrase: ")"

Phrase: ","

Phrase: "in addition to its putative role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035820:Role [Social Behavior]
   861   C1705810:Role [Conceptual Entity]

Phrase: "in amyloid plaque formation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
   734   C0333463:amyloid plaque [Acquired Abnormality]
   734   C2936349:Plaque, Amyloid [Acquired Abnormality]
Processing 00000000.tx.2: A1-42 freshly solubilized in water (non-aged A1-42), which was not neurotoxic without preaggregation, suppressed acetylcholine (ACh) synthesis in cholinergic neurons at very low concentrations (10-100 nM), although non-aged A1-40 was ineffective. 

Phrase: "A1-42 freshly"

Phrase: "solubilized in water"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   790   C0599638:WATER [Substance]
   790   C1550678:Water [Inorganic Chemical]
   718 E C0443350:Watery [Qualitative Concept]

Phrase: "(non-aged A1-42"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0001779:Aged [Organism Attribute]
   812   C0001792:Aged [Population Group]
   812   C1518422:Non [Functional Concept]
   812   C1999167:aged [Population Group]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "was"

Phrase: "not neurotoxic without preaggregation,"

Phrase: "suppressed acetylcholine (ACh) synthesis in cholinergic neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1154432:acetylcholine synthesis [Molecular Function]
   753   C0220781:synthesis [Biologic Function]
   753   C1883254:Synthesis [Activity]

Phrase: "at very low concentrations"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]
   734   C0442811:Very low [Finding]

Phrase: "(10-100 nM),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: "although"

Phrase: "non-aged A1-40"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0001779:Aged [Organism Attribute]
   812   C0001792:Aged [Population Group]
   812   C0439509:/40 [Temporal Concept]
   812   C1518422:Non [Functional Concept]
   812   C1999167:aged [Population Group]

Phrase: "was"

Phrase: "ineffective."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3242229:ineffective [Idea or Concept]
Processing 00000000.tx.3: Non-aged A1-42 impaired pyruvate dehydrogenase (PDH) activity by activating mitochondrial protein kinase I/glycogen synthase kinase-3, as we have already shown in hippocampal neurons (Hoshi, M., Takashima, A., Noguchi, K., Murayama, M., Sato, M., Kondo, S., Saitoh, Y., Ishiguro, K., Hoshino, T., and Imahori, K.(1996) Proc. Natl. Acad. Sci. U.S.A. 93, 2719-2723). 

Phrase: "Non-aged A1-42 impaired pyruvate dehydrogenase (PDH) activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   835   C1151688:pyruvate dehydrogenase activity [Molecular Function]
   793   C0205177:Activity [Functional Concept]
   793   C0439167:% activity [Quantitative Concept]
   793   C0441655:Activity [Activity]
   793   C1561536:*Activity [Idea or Concept]

Phrase: "by activating mitochondrial protein kinase I/glycogen synthase kinase-3,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   849   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   842   C1515146:I 3 [Cell]
   827   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   807   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   791   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   791   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "as"

Phrase: "we"

Phrase: "have"

Phrase: "already"

Phrase: "shown in hippocampal neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0019564:Hippocampal [Body Part, Organ, or Organ Component]
   770   C0027882:Neurons [Cell]
   737   C1547282:Show [Intellectual Product]

Phrase: "(Hoshi,"

Phrase: "M."

Phrase: ","

Phrase: "Takashima,"

Phrase: "A.,"

Phrase: "Noguchi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Murayama,"

Phrase: "M."

Phrase: ","

Phrase: "Sato,"

Phrase: "M."

Phrase: ","

Phrase: "Kondo,"

Phrase: "S."

Phrase: ","

Phrase: "Saitoh,"

Phrase: "Y.,"

Phrase: "Ishiguro,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hoshino,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Imahori,"

Phrase: "K.(1996"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: ")"

Phrase: "Proc. Natl. Acad. Sci. U.S.A. 93,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   835   C0041703:U.S.A. [Geographic Area]
           U S
   793   C0268596:ACAD [Disease or Syndrome]
   793   C1418943:PROC [Gene or Genome]
   793   C2700624:ACAD [Cell Function]
   793   C3642273:SCI [Professional or Occupational Group]

Phrase: "2719-2723"

Phrase: ")."
Processing 00000000.tx.4: Neither choline acetyltransferase activity nor choline metabolism was affected. 

Phrase: "Neither choline acetyltransferase activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1151953:choline acetyltransferase activity [Molecular Function]
   901   C1151922:acetyltransferase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0008407:Choline Acetyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1413376:CHOLINE ACETYLTRANSFERASE [Gene or Genome]

Phrase: "nor"

Phrase: "choline metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1156927:choline metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "was"

Phrase: "affected."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]
Processing 00000000.tx.5: Therefore, the major cause of reduced ACh synthesis was considered to be an inadequate supply of acetyl-CoA owing to PDH impairment. 

Phrase: "Therefore,"

Phrase: "the major cause of reduced ACh synthesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0015127:cause [Functional Concept]
   748   C0205164:Major [Qualitative Concept]
   748   C1524003:Cause [Conceptual Entity]

Phrase: "was"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "an inadequate supply of acetyl-CoA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0243163:supply [Idea or Concept]
   753   C0699914:supply [Quantitative Concept]
   753   C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
   753   C1561604:supply [Functional Concept]
   753   C1875802:SUPPLY [Medical Device]
   753   C1999230:Supply [Activity]

Phrase: "owing to PDH impairment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0684336:Impairment [Pathologic Function]
   734   C0034343:pyruvate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.6: Soluble A1-42 increases specifically in AD brain (Kuo, Y.-M., Emmerling, M.R., Vigo-Pelfrey, C., Kasunic, T.C., Kirkpatrick, J.B., Murdoch, G.H., Ball, M.J., and Roher, A.E.(1996) J.Biol. Chem. 271,4077-4081). 

Phrase: "Soluble A1-42 increases specifically in AD brain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:increases [Functional Concept]

Phrase: "(Kuo,"

Phrase: "Y.-"

Phrase: "M."

Phrase: ","

Phrase: "Emmerling,"

Phrase: "M."

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Vigo-Pelfrey,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Kasunic,"

Phrase: "T.C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "Kirkpatrick,"

Phrase: "J.B.,"

Phrase: "Murdoch,"

Phrase: "G.H.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0560020:g h [Quantitative Concept]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Ball,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706910:Ball [Manufactured Object]

Phrase: "M."

Phrase: "J.,"

Phrase: "and"

Phrase: "Roher,"

Phrase: "A.E.(1996"

Phrase: ")"

Phrase: "J.Biol. Chem. 271,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: "4077-4081"

Phrase: ")."
Processing 00000000.tx.7: This increase in soluble A1-42 may disturb cholinergic function, leading to the deterioration of memory and cognitive function that is characteristic of AD. 

Phrase: "This increase in soluble A1-42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "may"

Phrase: "disturb"

Phrase: "cholinergic function,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "leading to the deterioration of memory"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   753   C0025260:Memory [Mental Process]
   753   C0332152:Leading [Temporal Concept]
   753   C0700327:memory [Finding]
   753   C0868945:Deterioration [Phenomenon or Process]
   753   C1522538:Leading [Functional Concept]
   753   C1706377:Memory [Manufactured Object]
   719 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   719 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   719 E C2348269:Lead [Element, Ion, or Isotope]
   719 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "cognitive function"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0392335:cognitive function [Mental Process]
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1516691:Cognitive [Functional Concept]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "that"

Phrase: "is"

Phrase: "characteristic of AD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1521970:Characteristic [Qualitative Concept]
Processing 00000000.tx.8: INTRODUCTION Alzheimer's disease (AD)1 is a progressive dementia. 

Phrase: "INTRODUCTION Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "(AD)1"

Phrase: "is"

Phrase: "a progressive dementia."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0743039:Dementia, progressive [Disease or Syndrome]
   861   C0011265:dementia [Mental or Behavioral Dysfunction]
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]
Processing 00000000.tx.9: One of the most consistent abnormalities in AD brain is a severe loss of basal forebrain cholinergic neurons and cortical cholinergic innervations (3-11), together with other pathological features (amyloid plaques and neurofibrillary tangles) (12). 

Phrase: "One of the most consistent abnormalities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205447:One [Quantitative Concept]

Phrase: "in AD brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "a severe loss of basal forebrain cholinergic neurons"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   793   C0598940:Loss of neurons [Finding]
           neuron loss
   744   C1517945:Loss [Quantitative Concept]
   725 E C1850496:Neuronal loss [Finding]

Phrase: "and"

Phrase: "cortical cholinergic innervations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0021516:Innervation [Organ or Tissue Function]
   793   C0026828:Innervation [Organ or Tissue Function]
   793   C1619351:innervation [Qualitative Concept]

Phrase: "(3-11"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "together with other pathological features"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1521970:Feature [Qualitative Concept]
   827   C1706388:Feature [Conceptual Entity]
   827   C2346469:Feature [Qualitative Concept]
   827   C2348519:Feature [Qualitative Concept]

Phrase: "(amyloid plaques"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
  1000   C2936349:Plaques, Amyloid [Acquired Abnormality]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]

Phrase: "and"

Phrase: "neurofibrillary tangles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: ")"

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.10: The degree of cognitive dysfunction in AD patients is significantly correlated with decline in choline acetyltransferase (ChAT) activity, a cholinergic marker, and loss of cholinergic neurons (7, 13-15). 

Phrase: "The degree of cognitive dysfunction"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0441889:Degree [Qualitative Concept]
   760   C0449286:Degree [Quantitative Concept]
   760   C0542560:Degree [Intellectual Product]
   760   C1561545:degree [Quantitative Concept]
   760   C2348088:Degree [Quantitative Concept]

Phrase: "in AD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "is"

Phrase: "significantly"

Phrase: "correlated with decline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707520:Correlated [Qualitative Concept]

Phrase: "in choline acetyltransferase (ChAT) activity,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1151953:choline acetyltransferase activity [Molecular Function]
   901   C1151922:acetyltransferase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0008407:Choline Acetyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1413376:CHOLINE ACETYLTRANSFERASE [Gene or Genome]

Phrase: "a cholinergic marker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005516:Marker [Clinical Attribute]

Phrase: "and"

Phrase: "loss of cholinergic neurons"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   881   C0598940:Loss of neurons [Finding]
           neuron loss
   777 E C1850496:Neuronal loss [Finding]
   770   C1517945:Loss [Quantitative Concept]

Phrase: "(7,"

Phrase: "13-15"

Phrase: ")."
Processing 00000000.tx.11: Evidence from behavioral, pharmacological, neurochemical, and lesion studies further supports a role of these cholinergic deficits in the memory disturbances in normal aging and AD (16, 17). 

Phrase: "Evidence from behavioral, pharmacological, neurochemical,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]

Phrase: "and"

Phrase: "lesion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221198:Lesion [Finding]
  1000   C1546698:Lesion [Intellectual Product]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "a role of these cholinergic deficits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in the memory disturbances"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0233794:MEMORY DISTURBANCE [Mental or Behavioral Dysfunction]
   827   C2699787:Disturbance [Qualitative Concept]

Phrase: "in normal aging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001811:Ageing [Organism Function]

Phrase: "and"

Phrase: "AD (16,"

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.12: Cholinergic therapies based on acetylcholine esterase (AChE) inhibition have produced small, but well-attested improvements in AD patients (16). 

Phrase: "Cholinergic therapies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0087111:therapies [Therapeutic or Preventive Procedure]
   827 E C0039798:therapy [Functional Concept]
   827 E C1363945:Therapy [Finding]

Phrase: "based on acetylcholine esterase (AChE) inhibition"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   806   C0001044:Acetylcholine esterase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   760   C0014894:Esterase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1527178:Based [Functional Concept]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C1705938:Based [Idea or Concept]
   760   C3463820:Inhibition [Activity]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "have"

Phrase: "produced small,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0700321:Small [Quantitative Concept]

Phrase: "but"

Phrase: "well-attested improvements in AD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C2986411:Improvement [Conceptual Entity]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.13: These results suggest a critical involvement of cholinergic deficiency in the impaired learning and memory in AD. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a critical involvement of cholinergic deficiency"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1314939:Involvement [Functional Concept]

Phrase: "in the impaired learning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013621:learning [Educational Activity]
   861   C0023185:Learning [Mental Process]

Phrase: "and"

Phrase: "memory in AD."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0025260:Memory [Mental Process]
   790   C0700327:memory [Finding]
   790   C1706377:Memory [Manufactured Object]
   734 E C0679055:mnemonic [Mental Process]
Processing 00000000.tx.14: However, the basis for this cholinergic deficiency is unclear, and whether amyloid plaques or neurofibrillary tangles are related to the cholinergic deficits is so far unknown. 

Phrase: "However,"

Phrase: "the basis for this cholinergic deficiency"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1527178:Basis [Functional Concept]
   753   C1874451:Basis [Pharmacologic Substance]

Phrase: "is"

Phrase: "unclear,"

Phrase: "and"

Phrase: "whether"

Phrase: "amyloid plaques"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
  1000   C2936349:Plaques, Amyloid [Acquired Abnormality]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]

Phrase: "or"

Phrase: "neurofibrillary tangles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]

Phrase: "are"

Phrase: "related to the cholinergic deficits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   760   C0599668:cholinergic [Functional Concept]
   760   C2987487:deficits [Qualitative Concept]
   726 E C0162429:Deficit, NOS [Disease or Syndrome]
   726 E C0163712:Relate [Organic Chemical]

Phrase: "is"

Phrase: "so far unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.15: Amyloid plaques are mainly composed of insoluble aggregates of amyloid peptides (As). 

Phrase: "Amyloid plaques"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
  1000   C2936349:Plaques, Amyloid [Acquired Abnormality]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]

Phrase: "are"

Phrase: "mainly"

Phrase: "composed of insoluble aggregates of amyloid peptides"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   748   C0205418:aggregates [Qualitative Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "As"

Phrase: ")."
Processing 00000000.tx.16: In our previous work, aggregated A25-35, an active portion of A, was shown to suppress pyruvate dehydrogenase (PDH) activity in hippocampal neuronal cultures and to result in energy failure, which probably contributes to neuronal death, together with abnormal phosphorylation of (1). 

Phrase: "In our previous work,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043227:Work [Occupational Activity]

Phrase: "aggregated A25-35,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0332621:Aggregated [Functional Concept]
   793 E C0205418:Aggregate [Qualitative Concept]

Phrase: "an active portion of A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449719:Portion [Spatial Concept]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "suppress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "pyruvate dehydrogenase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0034343:pyruvate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0034354:pyruvate [Organic Chemical]
   861   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: "(PDH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0034343:pyruvate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0034354:pyruvate [Organic Chemical]
   861   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: ")"

Phrase: "activity in hippocampal neuronal cultures"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "result in energy failure,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0231174:Failure [Functional Concept]
   770   C0424589:Energy [Finding]
   770   C0542479:Energy [Natural Phenomenon or Process]
   770   C0680095:failure [Individual Behavior]
   770   C1274040:Result [Functional Concept]
   770   C1442080:Energy [Quantitative Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "which probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "contributes to neuronal death,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C2754100:neuron death [Cell Function]
   770   C0011065:Death [Organism Function]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C1306577:Death, NOS [Finding]
   770   C1880177:Contribute [Activity]

Phrase: "together with abnormal phosphorylation of (1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0031715:Phosphorylation [Molecular Function]
   812   C0205161:Abnormal [Qualitative Concept]
   812   C1158886:Phosphorylation [Molecular Function]
   812   C2347472:% Abnormal [Quantitative Concept]
   812   C2699333:ABNORMAL [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.17: Since PDH provides acetyl-CoA for acetylcholine (ACh) synthesis in cholinergic neurons, the above finding suggests the direct involvement of A in the cholinergic abnormality in AD by inhibiting PDH activity. 

Phrase: "Since"

Phrase: "PDH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0034343:pyruvate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0034354:pyruvate [Organic Chemical]
   861   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "acetyl-CoA for acetylcholine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0001026:Acetyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(ACh"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "synthesis in cholinergic neurons,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0220781:synthesis [Biologic Function]
   770   C1883254:Synthesis [Activity]

Phrase: "the above finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037088:Finding [Sign or Symptom]
   861   C0243095:Finding [Finding]
   861   C2825141:Finding [Finding]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "the direct involvement of A in the cholinergic abnormality"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1314939:Involvement [Functional Concept]

Phrase: "in AD"

Phrase: "by inhibiting PDH activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1151688:pyruvate dehydrogenase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.18: Among A species generated in vivo from amyloid precursor protein (APP), A1-40 is a major product of soluble As and is constitutively secreted in culture medium and cerebrospinal fluid, while A1-42 is produced in a lesser amount (18, 19). 

Phrase: "Among A species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705920:Species [Conceptual Entity]

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "in vivo from amyloid precursor protein (APP),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "A1-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: "is"

Phrase: "a major product of soluble"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1514468:product [Entity]
   760   C1704444:Product [Quantitative Concept]

Phrase: "As"

Phrase: "and"

Phrase: "is"

Phrase: "constitutively"

Phrase: "secreted in culture medium"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   770   C0009458:Medium [Intellectual Product]
   770   C0010453:Culture [Idea or Concept]
   770   C0220814:culture [Functional Concept]
   770   C0430400:Culture [Laboratory Procedure]
   770   C0439536:Medium [Quantitative Concept]
   770   C1327616:Secreted [Cell Function]
   770   C1705217:Medium [Substance]
   770   C2242979:Culture [Laboratory Procedure]
   770   C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "cerebrospinal fluid,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007806:Cerebrospinal Fluid [Body Substance]
  1000   C0007807:cerebrospinal fluid [Functional Concept]
   861   C0005889:FLUID [Body Substance]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]

Phrase: "while"

Phrase: "A1-42"

Phrase: "is"

Phrase: "produced in a lesser amount"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0547044:Lesser [Qualitative Concept]
   760   C1265611:Amount [Quantitative Concept]

Phrase: "(18,"

Phrase: "19"

Phrase: ")."
Processing 00000000.tx.19: Accumulating evidence indicates that increased production of A1-42 is the primary event that leads to the formation of amyloid plaques in AD. 

Phrase: "Accumulating evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "indicates"

Phrase: "that increased production of A1-42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033268:production [Occupational Activity]

Phrase: "is"

Phrase: "the primary event"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441471:Event [Event]

Phrase: "that"

Phrase: "leads to the formation of amyloid plaques"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   778   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
   778   C2936349:Plaques, Amyloid [Acquired Abnormality]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   748   C0181586:leads [Medical Device]
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   748   C1522492:Formation [Functional Concept]
   748   C1522538:Lead [Functional Concept]
   748   C2348269:Lead [Element, Ion, or Isotope]
   748   C3275067:LEAD [Therapeutic or Preventive Procedure]
   714 E C0011389:Plaque [Disease or Syndrome]
   714 E C0332461:Plaque [Finding]

Phrase: "in AD."
Processing 00000000.tx.20: Therefore, we focused on the effect of A1-42 on cholinergic function using a primary neuronal culture as an in vitro model system. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "focused on the effect of A1-42"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205234:Focused [Spatial Concept]
   748   C1280500:Effect [Qualitative Concept]
   748   C1285542:focused [Functional Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "on cholinergic function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a primary neuronal culture as an in vitro model system."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0010453:Culture [Idea or Concept]
   739   C0220814:culture [Functional Concept]
   739   C0430400:Culture [Laboratory Procedure]
   739   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.21: We report here that A1-42 freshly solubilized in water impairs ACh synthesis in cholinergic neurons without affecting neuronal survival. 

Phrase: "We"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "here"

Phrase: "that A1-42 freshly"

Phrase: "solubilized in water"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   790   C0599638:WATER [Substance]
   790   C1550678:Water [Inorganic Chemical]
   718 E C0443350:Watery [Qualitative Concept]

Phrase: "impairs"

Phrase: "ACh synthesis in cholinergic neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1154432:acetylcholine synthesis [Molecular Function]
   760   C0220781:synthesis [Biologic Function]
   760   C1883254:Synthesis [Activity]

Phrase: "without affecting neuronal survival."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   865   C1819944:neuron survival [Cell Function]
   827   C0038952:Survival [Activity]
   827   C0220921:survival [Functional Concept]
Processing 00000000.tx.22: Recently, the pool of oligomeric water-soluble A1-42 was found to be uniquely elevated in AD compared with normal brain (2). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "the pool of oligomeric water-soluble A1-42"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0337051:Pool [Geographic Area]
   744   C1509144:pool [Clinical Attribute]
   744   C2349200:Pool [Functional Concept]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "uniquely"

Phrase: "elevated in AD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205250:Elevated [Qualitative Concept]
   790   C3163633:Elevated [Qualitative Concept]

Phrase: "compared with normal brain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C1707455:Compared [Activity]
   770   C2347086:% Normal [Quantitative Concept]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.23: Taken together, the findings suggest a possible role of soluble A1-42 in AD pathogenesis in addition to its contribution to amyloid plaque formation. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "the findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a possible role of soluble A1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in AD pathogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0543483:pathogenesis [Functional Concept]
   861   C0699748:Pathogenesis [Pathologic Function]

Phrase: "in addition to its contribution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880177:Contribution [Activity]

Phrase: "to amyloid plaque formation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
   734   C0333463:amyloid plaque [Acquired Abnormality]
   734   C2936349:Plaque, Amyloid [Acquired Abnormality]
Processing 00000000.tx.24: EXPERIMENTAL PROCEDURES Peptides Synthetic A1-40 peptide was synthesized and purified as described previously (20). 

Phrase: "EXPERIMENTAL PROCEDURES Peptides Synthetic A1-40 peptide"

Phrase: "was"

Phrase: "synthesized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883254:Synthesized [Activity]

Phrase: "and"

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.25: Synthetic A1-42 peptide was obtained from Bachem (Torrance, CA). 

Phrase: "Synthetic A1-42 peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   902   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "obtained from Bachem"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "(Torrance,"

Phrase: "CA)."
Processing 00000000.tx.26: Lyophilized peptides were stored at 20C. 

Phrase: "Lyophilized peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "stored at 20C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1698986:Store [Functional Concept]
Processing 00000000.tx.27: Non-aged As were prepared by freshly dissolving the lyophilized peptides in autoclaved MilliQ water to 200M just before use. 

Phrase: "Non-aged"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0001779:Aged [Organism Attribute]
   861   C0001792:Aged [Population Group]
   861   C1518422:Non [Functional Concept]
   861   C1999167:aged [Population Group]

Phrase: "As"

Phrase: "were"

Phrase: "prepared by freshly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1521827:Prepare [Functional Concept]

Phrase: "dissolving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1549535:Dissolve [Functional Concept]

Phrase: "the lyophilized peptides in autoclaved MilliQ water"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "to 200M just"

Phrase: "before"

Phrase: "use."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]
Processing 00000000.tx.28: Aged A1-42 was produced by dissolving the peptide in autoclaved MilliQ water to 350M and incubating at 37C for 7days as previously reported (21). 

Phrase: "Aged A1-42"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0001779:Aged [Organism Attribute]
   827   C0001792:Aged [Population Group]
   827   C1999167:aged [Population Group]

Phrase: "was"

Phrase: "produced by dissolving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1549535:Dissolve [Functional Concept]

Phrase: "the peptide in autoclaved MilliQ water"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "to 350M"

Phrase: "and"

Phrase: "incubating at 37C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:incubating [Laboratory Procedure]

Phrase: "for 7days"

Phrase: "as"

Phrase: "previously"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.29: Cell Culture Primary cultures from rat septum regions, which include septal and basal forebrain cholinergic neurons, were prepared and plated (1). 

Phrase: "Cell Culture Primary cultures from rat septum regions,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   793   C1449562:Primary Cell Culture [Laboratory Procedure]
           Primary Cell Cultures
   789   C1748485:primary cell septum [Cell Component]
   767   C0007585:Cell Cultures [Laboratory Procedure]
   767   C1325753:primary septum [Cell Component]
   744   C0010453:Cultures [Idea or Concept]
   744   C0205225:Primary [Qualitative Concept]
   744   C0439631:Primary [Therapeutic or Preventive Procedure]

Phrase: "which"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "septal"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0442004:Septal [Spatial Concept]
   928 E C0723285:Septa [Antibiotic,Organic Chemical]
   928 E C1327729:septum [Cell Component]
   928 E C2362924:Septum [Classification]
   928 E C2987494:Septa [Medical Device]

Phrase: "and"

Phrase: "basal forebrain cholinergic neurons,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C2333949:Cholinergic Neurons [Cell]
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "and"

Phrase: "plated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005971:Plate [Medical Device]
   966   C1139930:plate [Medical Device]
   966   C3537155:Plate [Manufactured Object]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.30: After 3days, the medium was changed to serum-free neurobasal medium with B27 and L-glutamate supplements (Life Technologies, Inc.). 

Phrase: "After 3days,"

Phrase: "the medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "changed to serum-free neurobasal medium"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   753   C0009458:Medium [Intellectual Product]
   753   C0229671:Serum [Body Substance]
   753   C0332296:free [Functional Concept]
   753   C0392747:Changed [Functional Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C0443172:Changed [Quantitative Concept]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   753   C1705217:Medium [Substance]
   753   C1880497:Free [Qualitative Concept]
   753   C1996904:Free [Qualitative Concept]
   753   C3244283:medium [Intellectual Product]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "with B27"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1537935:B27 [Gene or Genome]

Phrase: "and"

Phrase: "L-glutamate supplements"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0242295:Supplement [Food]
   793   C1947943:Supplement [Intellectual Product]
   793   C2348609:Supplement [Functional Concept]
   734   C0220839:L-Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: "Inc."

Phrase: ")."
Processing 00000000.tx.31: Two days later, non-aged A was added to the medium. 

Phrase: "Two days later,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0439228:days [Temporal Concept]
   793 E C0332173:/day [Temporal Concept]
   793 E C0439505:/day [Temporal Concept]

Phrase: "non-aged"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0001779:Aged [Organism Attribute]
   861   C0001792:Aged [Population Group]
   861   C1518422:Non [Functional Concept]
   861   C1999167:aged [Population Group]

Phrase: "A"

Phrase: "was"

Phrase: "added to the medium."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0009458:Medium [Intellectual Product]
   770   C0439536:Medium [Quantitative Concept]
   770   C1524062:Added [Functional Concept]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]
   737 E C1883712:Add [Functional Concept]
Processing 00000000.tx.32: Biochemical Assays Intracellular ACh was determined using an HPLC-electrochemical detector system (1, 22). 

Phrase: "Biochemical Assays Intracellular ACh"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an HPLC-electrochemical detector system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "22"

Phrase: ")."
Processing 00000000.tx.33: Rate of ACh synthesis from [2-14C]pyruvate was measured by the modified method of Gibson et al. 

Phrase: "Rate of ACh synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0871208:Rate [Activity]
   770   C1521828:Rate [Quantitative Concept]

Phrase: "from"

Phrase: "[2-14C"

Phrase: "]pyruvate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034354:pyruvate [Organic Chemical]
  1000   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: "was"

Phrase: "measured by the modified method of Gibson et al."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   762   C0205349:Modified By [Qualitative Concept]
   742   C0025663:Method [Intellectual Product]
   742   C0392747:Modified [Functional Concept]
   742   C0444706:Measured [Qualitative Concept]
   742   C0449851:Method [Functional Concept]
   742   C0871511:METHOD [Intellectual Product]
   742   C3541902:MEASURED [Diagnostic Procedure]
   708 E C0079809:Measure [Quantitative Concept]
   708 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.34: (23). 

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.35: Cultures were incubated with various concentrations of non-aged A1-42 for 12h, and [2-14C]pyruvate (1Ci/ml) was added to the medium. 

Phrase: "Cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "incubated with various concentrations of non-aged A1-42"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   742   C0001779:Aged [Organism Attribute]
   742   C0001792:Aged [Population Group]
   742   C0086045:Concentrations [Mental Process]
   742   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   742   C1439852:Incubated [Laboratory Procedure]
   742   C1518422:Non [Functional Concept]
   742   C1999167:aged [Population Group]
   708 E C1446561:Concentration [Quantitative Concept]

Phrase: "for 12h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456695:/12h [Temporal Concept]

Phrase: "and ["

Phrase: "2-14C"

Phrase: "]pyruvate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034354:pyruvate [Organic Chemical]
  1000   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: "(1Ci/ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "was"

Phrase: "added to the medium."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0009458:Medium [Intellectual Product]
   770   C0439536:Medium [Quantitative Concept]
   770   C1524062:Added [Functional Concept]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]
   737 E C1883712:Add [Functional Concept]
Processing 00000000.tx.36: After a 40-min incubation, cultures were washed with PBS, extracted with 5mM Tris-Cl (pH 7.5), 0.5% Triton X-100, and scraped off. 

Phrase: "After a 40-min incubation,"

Phrase: "cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "washed with PBS,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1548982:Washed [Idea or Concept]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   756 E C0441648:Wash [Activity]

Phrase: "extracted with 5mM Tris-Cl (pH 7.5"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   770   C1882074:pH 7 [Qualitative Concept]
   767   C1416653:cl-5 [Gene or Genome]
   744   C0020283:[pH] [Quantitative Concept]
   744   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   744   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   744   C0185115:Extracted [Therapeutic or Preventive Procedure]
   744   C0450407:ph+ [Finding]
   744   C0450408:ph++ [Finding]
   744   C0450409:ph+++ [Finding]
   744   C0596019:Cl - [Element, Ion, or Isotope]
   744   C0814229:TRI [Intellectual Product]
   744   C3541890:EXTRACTED [Finding]
   711 E C2828366:Extract [Substance]

Phrase: ")"

Phrase: ","

Phrase: "0.5% Triton X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]

Phrase: "and"

Phrase: "scraped off."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0184933:scraped [Therapeutic or Preventive Procedure]
   833   C0444082:scraped [Body Substance]
Processing 00000000.tx.37: Supernatants were recovered by centrifugation, and ACh was extracted by adding 14mM sodium phosphate buffer (pH 7.4) containing sodium tetraphenylborate and acetonitrile, followed by toluene-based scintillant. 

Phrase: "Supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "recovered by centrifugation,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0007703:Centrifugation [Laboratory Procedure]
   790   C0521108:recovered [Qualitative Concept]
   756 E C2004454:recover [Organism Function]

Phrase: "and"

Phrase: "ACh"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "extracted by adding 14mM sodium phosphate buffer"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   814   C3256935:sodium phosphate buffer [Pharmacologic Substance]
   778   C0074757:sodium phosphate [Inorganic Chemical,Pharmacologic Substance]
   778   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   748   C0031701:phosphate [Organophosphorus Compound]
   748   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   748   C0185115:Extracted [Therapeutic or Preventive Procedure]
   748   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   748   C3541890:EXTRACTED [Finding]
   714   C1883712:Add [Functional Concept]
   714 E C2828366:Extract [Substance]

Phrase: "(pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "containing sodium tetraphenylborate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0037558:Sodium Tetraphenylborate [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0039696:Tetraphenylborate [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "acetonitrile,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050456:acetonitrile [Organic Chemical]

Phrase: "followed by toluene-based scintillant."
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0040383:Toluene [Organic Chemical]
   760   C1527178:Based [Functional Concept]
   760   C1556063:Toluene [Intellectual Product]
   760   C1705938:Based [Idea or Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1719822:Follow [Intellectual Product]
   726 E C1880279:Base [Biomedical or Dental Material]
Processing 00000000.tx.38: Incorporation of radioactivity from [2-14C]pyruvate into ACh was proportional to time, and the rate of ACh synthesis was calculated as cpm/min. 

Phrase: "Incorporation of radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0243126:incorporation [Functional Concept]

Phrase: "from"

Phrase: "[2-14C"

Phrase: "]pyruvate into ACh"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034354:pyruvate [Organic Chemical]
   790   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: "was"

Phrase: "proportional to time,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0205351:Proportional [Qualitative Concept]
   718 E C1709707:Proportion [Quantitative Concept]

Phrase: "and"

Phrase: "the rate of ACh synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "calculated as cpm/min."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0444686:Calculated [Functional Concept]
   770   C0702093:/min [Temporal Concept]
   770   C1441506:Calculated [Activity]
   770   C1443182:Calculated [Laboratory Procedure]
Processing 00000000.tx.39: ChAT activity was assayed as described (1). 

Phrase: "ChAT activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1151953:choline acetyltransferase activity [Molecular Function]
   901   C1151922:acetyltransferase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0008407:Choline Acetyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1413376:CHOLINE ACETYLTRANSFERASE [Gene or Genome]

Phrase: "was"

Phrase: "assayed as described"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1552738:described [Idea or Concept]
   756   C0005507:Assay [Laboratory Procedure]
   756   C0243073:assay [Qualitative Concept]
   756   C1510438:Assay [Laboratory Procedure]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.40: ATP content in the culture was measured by Luciferase reaction using a Promega kit (FF2000 and FF2040) with a luminometer, Lumat LB9501/16 (Berthold Japan, Tokyo). 

Phrase: "ATP content in the culture"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0423896:Content [Mental Process]
   760   C0456205:Content [Conceptual Entity]

Phrase: "was"

Phrase: "measured by Luciferase reaction"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   770   C0443286:Reaction [Functional Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C1114821:Reaction [Clinical Attribute]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Promega kit (FF2000"

Phrase: "and"

Phrase: "FF2040"

Phrase: ")"

Phrase: "with a luminometer,"

Phrase: "Lumat LB9501/16"

Phrase: "(Berthold Japan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022341:Japan [Geographic Area]

Phrase: "Tokyo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: ")."
Processing 00000000.tx.41: AChE activity was determined in terms of production of [3H]acetate from [acetyl-3H]choline iodide as described (24). 

Phrase: "AChE activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1149827:acetylcholinesterase activity [Molecular Function]
   901   C1149811:esterase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0001044:Acetylcholine esterase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "determined in terms of production of [3H"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0033268:production [Occupational Activity]
   748   C1442460:3H [Temporal Concept]
   714   C1515273:Term [Temporal Concept]
   714   C1705313:Term [Idea or Concept]
   714   C2826302:TERM [Intellectual Product]

Phrase: "]acetate from"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]

Phrase: "[acetyl-3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442460:3H [Temporal Concept]

Phrase: "]choline iodide as described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0021966:Iodide [Inorganic Chemical]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.42: Choline uptake by the culture was measured as described (25). 

Phrase: "Choline uptake by the culture"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243144:Uptake [Physiologic Function]
   760   C0347980:% uptake [Quantitative Concept]

Phrase: "was"

Phrase: "measured as described"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0444706:Measured [Qualitative Concept]
   790   C1552738:described [Idea or Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.43: Cultures were incubated with various concentrations of non-aged A1-42 for 12h, and [methyl-3H]choline chloride (3Ci/ml) was added to the medium. 

Phrase: "Cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "incubated with various concentrations of non-aged A1-42"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   742   C0001779:Aged [Organism Attribute]
   742   C0001792:Aged [Population Group]
   742   C0086045:Concentrations [Mental Process]
   742   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   742   C1439852:Incubated [Laboratory Procedure]
   742   C1518422:Non [Functional Concept]
   742   C1999167:aged [Population Group]
   708 E C1446561:Concentration [Quantitative Concept]

Phrase: "for 12h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456695:/12h [Temporal Concept]

Phrase: "and ["

Phrase: "methyl-3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442460:3H [Temporal Concept]

Phrase: "]choline chloride"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0008409:Choline Chloride [Organic Chemical,Pharmacologic Substance]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "(3Ci/ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "was"

Phrase: "added to the medium."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0009458:Medium [Intellectual Product]
   770   C0439536:Medium [Quantitative Concept]
   770   C1524062:Added [Functional Concept]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]
   737 E C1883712:Add [Functional Concept]
Processing 00000000.tx.44: Forty min later, cultures were washed four times with PBS, treated with trichloroacetic acid (5% w/v), and scraped off. 

Phrase: "Forty min later,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0702093:/min [Temporal Concept]

Phrase: "cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "four times with PBS,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0040223:times [Temporal Concept]
   770   C1632851:Times [Quantitative Concept]
   737 E C3541383:Time [Temporal Concept]

Phrase: "treated with trichloroacetic acid"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "(5% w/v"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "scraped off."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0184933:scraped [Therapeutic or Preventive Procedure]
   833   C0444082:scraped [Body Substance]
Processing 00000000.tx.45: Supernatants were obtained by centrifugation, neutralized with 1M Tris buffer (pH 7.8), and counted for radioactivity in toluene-based scintillant. 

Phrase: "Supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "obtained by centrifugation,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0007703:Centrifugation [Laboratory Procedure]
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "neutralized with 1M Tris buffer (pH 7.8"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   770   C1882074:pH 7 [Qualitative Concept]
   767   C0492253:PH BUFFER [Medical Device]
   744   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0020283:[pH] [Quantitative Concept]
   744   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   744   C0450407:ph+ [Finding]
   744   C0450408:ph++ [Finding]
   744   C0450409:ph+++ [Finding]
   744   C0470296:1M [Quantitative Concept]
   744   C0814229:TRI [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "counted for radioactivity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0034553:Radioactivity [Natural Phenomenon or Process]
   756   C0750480:Count [Activity]
   756   C1705566:Count [Quantitative Concept]

Phrase: "in toluene-based scintillant."
Processing 00000000.tx.46: PDH activity was measured as production of [14C]acetyl-CoA from [2-14C]pyruvate with an excess amount of ChAT, which converted the produced [14C]acetyl-CoA into [14C]ACh. 

Phrase: "PDH activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1151688:pyruvate dehydrogenase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0034343:pyruvate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "measured as production of [14C"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0033268:production [Occupational Activity]
   760   C0444706:Measured [Qualitative Concept]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "]acetyl-CoA from"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   882   C0001026:Acetyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "[2-14C"

Phrase: "]pyruvate with an excess amount of ChAT,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0034354:pyruvate [Organic Chemical]
   744   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: "which"

Phrase: "converted"

Phrase: "the produced"

Phrase: "[14C"

Phrase: "]acetyl-CoA into"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   882   C0001026:Acetyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "[14C"

Phrase: "]ACh."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.47: After non-aged A1-42 treatment, cultures were washed with PBS, scraped off in 10mM potassium phosphate buffer (pH 7.4), 1mM EGTA, 1mM EDTA, and 0.1% Triton X-100, frozen, and thawed. 

Phrase: "After non-aged A1-42 treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0039798:treatment [Functional Concept]
   804   C0087111:Treatment [Therapeutic or Preventive Procedure]
   804   C1522326:Treatment [Functional Concept]
   804   C1533734:Treatment [Therapeutic or Preventive Procedure]
   804   C1705169:Treatment [Conceptual Entity]
   804   C3538994:TREATMENT [Research Activity]

Phrase: "cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "washed with PBS,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1548982:Washed [Idea or Concept]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   756 E C0441648:Wash [Activity]

Phrase: "scraped off"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0184933:scraped [Therapeutic or Preventive Procedure]
   833   C0444082:scraped [Body Substance]

Phrase: "in 10mM potassium phosphate buffer"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0071778:potassium phosphate [Inorganic Chemical,Pharmacologic Substance]
   861   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C0032821:Potassium [Element, Ion, or Isotope]
   812   C0597277:Potassium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "(pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "1mM EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "1mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "0.1% Triton X-100,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]

Phrase: "frozen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016701:Frozen [Natural Phenomenon or Process]
  1000   C0677542:Frozen [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "thawed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710378:Thaw [Laboratory Procedure]
Processing 00000000.tx.48: This homogenate was incubated at 37C for 40min in the standard reaction buffer for PDH activity (1) (50mM potassium phosphate buffer (pH 8.0), 2.5mM NAD, 0.2mM thiamin pyrophosphate, 0.13mM CoA, and 2.6mM L-cysteine) containing 1mM choline chloride, ChAT (Sigma, C-3388, 0.05unit/assay), and 1mM [2-14C]pyruvate (0.5Ci/assay). 

Phrase: "This homogenate"

Phrase: "was"

Phrase: "incubated at 37C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 40min"

Phrase: "in the standard reaction buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "for PDH activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1151688:pyruvate dehydrogenase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0034343:pyruvate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "(50mM potassium phosphate buffer"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0071778:potassium phosphate [Inorganic Chemical,Pharmacologic Substance]
   861   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C0032821:Potassium [Element, Ion, or Isotope]
   812   C0597277:Potassium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "(pH 8.0"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "2.5mM NAD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0027270:NAD+ [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "0.2mM thiamin pyrophosphate,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0039848:Thiamine Pyrophosphate [Organic Chemical,Pharmacologic Substance,Vitamin]
   812   C0034320:Pyrophosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0039840:Thiamine [Organic Chemical,Pharmacologic Substance,Vitamin]
   812   C3252566:Pyrophosphate [Inorganic Chemical,Pharmacologic Substance]

Phrase: "0.13mM CoA,"

Phrase: "and"

Phrase: "2.6mM L-cysteine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010654:L-Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Cysteine

Phrase: ")"

Phrase: "containing 1mM choline chloride,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0008409:Choline Chloride [Organic Chemical,Pharmacologic Substance]
   812   C0008203:Chloride, NOS [Inorganic Chemical]
   812   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "ChAT"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0008407:Choline Acetyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413376:CHOLINE ACETYLTRANSFERASE [Gene or Genome]
   861   C0001068:Acetyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0001390:Acetyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0008405:Choline [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "(Sigma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: "C-3388,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "0.05unit/assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "1mM"

Phrase: "[2-14C"

Phrase: "]pyruvate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034354:pyruvate [Organic Chemical]
  1000   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: "(0.5Ci/assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: ")."
Processing 00000000.tx.49: The reaction was terminated by adding 14mM sodium phosphate buffer (pH 7.4) containing sodium tetraphenylborate and acetonitrile, followed by toluene-based scintillant. 

Phrase: "The reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "terminated by adding 14mM sodium phosphate buffer"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   814   C3256935:sodium phosphate buffer [Pharmacologic Substance]
   778   C0074757:sodium phosphate [Inorganic Chemical,Pharmacologic Substance]
   778   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   748   C0031701:phosphate [Organophosphorus Compound]
   748   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   748   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1553404:terminated [Idea or Concept]
   748   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   748   C2348570:Terminated [Functional Concept]
   714   C1883712:Add [Functional Concept]

Phrase: "(pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "containing sodium tetraphenylborate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0037558:Sodium Tetraphenylborate [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0039696:Tetraphenylborate [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "acetonitrile,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050456:acetonitrile [Organic Chemical]

Phrase: "followed by toluene-based scintillant."
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0040383:Toluene [Organic Chemical]
   760   C1527178:Based [Functional Concept]
   760   C1556063:Toluene [Intellectual Product]
   760   C1705938:Based [Idea or Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1719822:Follow [Intellectual Product]
   726 E C1880279:Base [Biomedical or Dental Material]
Processing 00000000.tx.50: AChE Cytochemistry AChE staining was performed as described (26). 

Phrase: "AChE Cytochemistry AChE staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0487602:Staining [Laboratory Procedure]
   799   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "performed as described"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0884358:Performed [Functional Concept]
   790   C1552738:described [Idea or Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.51: Briefly, after aged A1-42 or non-aged A1-42 treatments at 10 M for 24h, cultures were washed with PBS, fixed for 30min with 4% paraformaldehyde at room temperature, washed with PBS, and then incubated for 3days at 4C in 50mM acetate buffer (pH 5.0) containing 4mM acetylthiocholine iodide, 2mM copper sulfate, 10mM glycine, and 10mg/ml gelatin. 

Phrase: "Briefly,"

Phrase: "after"

Phrase: "aged A1-42"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0001779:Aged [Organism Attribute]
   827   C0001792:Aged [Population Group]
   827   C1999167:aged [Population Group]

Phrase: "or"

Phrase: "non-aged A1-42 treatments at 10 M"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   744   C0087111:Treatments [Therapeutic or Preventive Procedure]
   711 E C0039798:treatment [Functional Concept]
   711 E C1522326:Treatment [Functional Concept]
   711 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   711 E C1705169:Treatment [Conceptual Entity]
   711 E C3538994:TREATMENT [Research Activity]

Phrase: "for 24h,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "washed with PBS,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1548982:Washed [Idea or Concept]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   756 E C0441648:Wash [Activity]

Phrase: "fixed for 30min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0231441:Fixed [Finding]
   790   C0443218:Fixed [Qualitative Concept]
   790   C2827483:Fixed [Body Substance]

Phrase: "with 4% paraformaldehyde"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "at room temperature,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "washed with PBS,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1548982:Washed [Idea or Concept]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   756 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated for 3days"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "in 50mM acetate buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(pH 5.0"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "containing 4mM acetylthiocholine iodide,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2742722:acetylthiocholine iodide [Organic Chemical]
   812   C0021966:Iodide [Inorganic Chemical]

Phrase: "2mM copper sulfate,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0056301:Copper Sulfate [Inorganic Chemical,Pharmacologic Substance]
   827   C0009968:Copper [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0038720:Sulfate [Inorganic Chemical]
   827   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   827   C2347872:Copper+ [Element, Ion, or Isotope]
   827   C2348263:Copper [Element, Ion, or Isotope]
   827   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "10mM glycine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017890:Glycine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0522461:Glycine [Plant]

Phrase: "and"

Phrase: "10mg/ml gelatin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
   827   C1145617:Gelatin [Food]
Processing 00000000.tx.52: Nonspecific cholinesterases were inhibited by addition of 0.2mM ethopropagine in the above medium. 

Phrase: "Nonspecific cholinesterases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   983   C0033791:Non-specific cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
       E   Cholinesterase
   861   C0008429:Cholinesterases [Amino Acid, Peptide, or Protein,Enzyme]
   827 E C0728810:Cholinesterase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "inhibited by addition of 0.2mM ethopropagine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0311403:Inhibited [Qualitative Concept]
   748   C1883712:Addition [Functional Concept]

Phrase: "in the above medium."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]
Processing 00000000.tx.53: Then, the gelatin was dissolved by incubation at 37C. 

Phrase: "Then,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "the gelatin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
  1000   C1145617:Gelatin [Food]

Phrase: "was"

Phrase: "dissolved by incubation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1549535:Dissolve [Functional Concept]

Phrase: "at 37C."
Processing 00000000.tx.54: Cultures were washed with water, exposed for 1min to 1.25% Na2S, washed with water, and exposed for 1min to 1% AgNO3. 

Phrase: "Cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "washed with water,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   790   C0599638:WATER [Substance]
   790   C1548982:Washed [Idea or Concept]
   790   C1550678:Water [Inorganic Chemical]
   756 E C0441648:Wash [Activity]
   718 E C0443350:Watery [Qualitative Concept]

Phrase: "exposed for 1min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332157:Exposed [Clinical Attribute]

Phrase: "to 1.25% Na2S,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0074770:Na2S [Inorganic Chemical,Pharmacologic Substance]

Phrase: "washed with water,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   790   C0599638:WATER [Substance]
   790   C1548982:Washed [Idea or Concept]
   790   C1550678:Water [Inorganic Chemical]
   756 E C0441648:Wash [Activity]
   718 E C0443350:Watery [Qualitative Concept]

Phrase: "and"

Phrase: "exposed for 1min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332157:Exposed [Clinical Attribute]

Phrase: "to 1% AgNO3."
Processing 00000000.tx.55: Assay for Protein Kinase I/Glycogen Synthase Kinase-3 (TPKI/GSK-3) Activity After non-aged A1-42 treatment, mitochondrial pellets were prepared from the culture (1) and disrupted in a buffer (10 mM Tris-Cl (pH 7.4), 1mM EGTA, 1mM EDTA, 50mM NaCl, 50mM NaF, 50mM -glycerophosphate, 0.5mg/ml benzamidine, 1g/ml antipain and leupeptin, 30nM okadaic acid, 1mM phenylmethylsulfonyl fluoride, 1mM vanadate, and 0.5% Tween 20). 

Phrase: "Assay for Protein Kinase I/Glycogen Synthase Kinase-3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0005507:Assay [Laboratory Procedure]
   742   C0243073:assay [Qualitative Concept]
   742   C1510438:Assay [Laboratory Procedure]

Phrase: "(TPKI/GSK-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0244989:GSK-3 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1325174:GSK [Molecular Function]

Phrase: ")"

Phrase: "Activity After non-aged A1-42 treatment,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]
   738   C1704532:Active Treatment [Therapeutic or Preventive Procedure]

Phrase: "mitochondrial pellets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0993610:pellets [Biomedical or Dental Material]
   827 E C0441436:Pellet [Manufactured Object]
   827 E C1998480:Pellet [Quantitative Concept]

Phrase: "were"

Phrase: "prepared from the culture"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0010453:Culture [Idea or Concept]
   770   C0220814:culture [Functional Concept]
   770   C0430400:Culture [Laboratory Procedure]
   770   C2242979:Culture [Laboratory Procedure]
   737   C1521827:Prepare [Functional Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "disrupted in a buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0332454:Disrupted [Qualitative Concept]

Phrase: "(10 mM Tris-Cl (pH 7.4"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   829   C2678549:PH-4 [Gene or Genome]
   818   C1882074:pH 7 [Qualitative Concept]
   795   C0020283:[pH] [Quantitative Concept]
   795   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   795   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   795   C0450407:ph+ [Finding]
   795   C0450408:ph++ [Finding]
   795   C0450409:ph+++ [Finding]
   795   C0596019:Cl - [Element, Ion, or Isotope]
   795   C0814229:TRI [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "1mM EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "1mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "50mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "50mM NaF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037508:NaF [Biomedical or Dental Material,Inorganic Chemical]
   861   C1366571:NAF [Gene or Genome]
   861   C1705592:NAF [Gene or Genome]

Phrase: "50mM -glycerophosphate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017881:glycerophosphate [Carbohydrate,Lipid]

Phrase: "0.5mg/ml benzamidine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0053140:benzamidine [Organic Chemical,Pharmacologic Substance]

Phrase: "1g/ml antipain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003403:Antipain [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "30nM okadaic acid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0069389:Ocadaic Acid [Hazardous or Poisonous Substance,Organic Chemical]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "1mM phenylmethylsulfonyl fluoride,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   827   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "1mM vanadate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0042305:Vanadate [Inorganic Chemical]

Phrase: "and"

Phrase: "0.5% Tween 20"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   861   C0444499:0/5 [Quantitative Concept]
   833 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   812   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   756 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.56: TPKI/GSK-3 activity was determined by an immunoprecipitation assay using modified phosphoglycogen synthase peptide as a substrate (1). 

Phrase: "TPKI/GSK-3 activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "determined by an immunoprecipitation assay"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0005507:Assay [Laboratory Procedure]
   760   C0021069:Immunoprecipitation [Laboratory Procedure]
   760   C0243073:assay [Qualitative Concept]
   760   C1510438:Assay [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "modified phosphoglycogen synthase peptide as a substrate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0030952:peptide synthase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.57: RESULTS Freshly Dissolved A1-40 and A1-42 (Non-aged A1-40 and Non-aged A1-42) Are Not Neurotoxic Primary septal cultures have been established from rat septum regions that include septal and basal forebrain cholinergic neurons (1). 

Phrase: "RESULTS Freshly Dissolved A1-40"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0439509:/40 [Temporal Concept]
   771   C1274040:Result [Functional Concept]
   771   C1546471:Result [Idea or Concept]
   771   C1549535:Dissolve [Functional Concept]
   771   C2825142:Result [Finding]

Phrase: "and"

Phrase: "A1-42"

Phrase: "(Non-aged A1-40"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0001779:Aged [Organism Attribute]
   812   C0001792:Aged [Population Group]
   812   C0439509:/40 [Temporal Concept]
   812   C1518422:Non [Functional Concept]
   812   C1999167:aged [Population Group]

Phrase: "and"

Phrase: "Non-aged A1-42"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0001779:Aged [Organism Attribute]
   812   C0001792:Aged [Population Group]
   812   C1518422:Non [Functional Concept]
   812   C1999167:aged [Population Group]

Phrase: ")"

Phrase: "Are"

Phrase: "Not Neurotoxic Primary septal cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   804   C0010453:Cultures [Idea or Concept]
   771 E C0220814:culture [Functional Concept]
   771 E C0430400:Culture [Laboratory Procedure]
   771 E C2242979:Culture [Laboratory Procedure]

Phrase: "have"

Phrase: "been"

Phrase: "established from rat septum regions"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   760   C0443211:Established [Qualitative Concept]
   760   C1272684:Established [Qualitative Concept]
   760   C1327729:septum [Cell Component]
   760   C2362924:Septum [Classification]
   754   C0752059:Septal Region [Body Part, Organ, or Organ Component]
   726   C0017446:Region [Geographic Area]
   726   C0205147:Region [Spatial Concept]

Phrase: "that"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "septal"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0442004:Septal [Spatial Concept]
   928 E C0723285:Septa [Antibiotic,Organic Chemical]
   928 E C1327729:septum [Cell Component]
   928 E C2362924:Septum [Classification]
   928 E C2987494:Septa [Medical Device]

Phrase: "and"

Phrase: "basal forebrain cholinergic neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C2333949:Cholinergic Neurons [Cell]
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.58: A is normally secreted in vivo as a soluble form, which aggregates into insoluble amyloid fibrils to form amyloid plaques (21, 27). 

Phrase: "A"

Phrase: "is"

Phrase: "normally"

Phrase: "secreted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:Secreted [Cell Function]

Phrase: "in vivo as a soluble form,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "which"

Phrase: "aggregates into insoluble amyloid fibrils to"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C1449651:Amyloid Fibrils [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0205418:Aggregate [Qualitative Concept]
   753   C0225328:fibrils [Cell Component]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   719 E C1948066:Fibril [Physical Object]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "amyloid plaques"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
  1000   C2936349:Plaques, Amyloid [Acquired Abnormality]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]

Phrase: "(21,"

Phrase: "27"

Phrase: ")."
Processing 00000000.tx.59: Synthetic A required preincubation for 2-7 days at 37C to produce insoluble amyloid fibrils, which were cytotoxic to septal cultures (Fig. 1, B and F), as is consistent with the previous report (21). 

Phrase: "Synthetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883254:synthetic [Activity]

Phrase: "A required preincubation for 2-7 days"

Phrase: "at 37C to"

Phrase: "produce"

Phrase: "insoluble amyloid fibrils,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1449651:Amyloid Fibrils [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0225328:fibrils [Cell Component]
   793 E C1948066:Fibril [Physical Object]

Phrase: "which"

Phrase: "were"

Phrase: "cytotoxic to septal cultures"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   770   C1511636:cytotoxic [Functional Concept]

Phrase: "(Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "F),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "as is consistent with the previous report"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.60: Here, we use synthetic A1-40 and A1-42 peptides solubilized freshly in distilled water, which we designate as non-aged A1-40 and non-aged A1-42, respectively. 

Phrase: "Here,"

Phrase: "we"

Phrase: "use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "synthetic A1-40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439509:/40 [Temporal Concept]
   827   C1883254:synthetic [Activity]

Phrase: "and"

Phrase: "A1-42 peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "solubilized"

Phrase: "freshly in distilled water,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0790233:Distilled water [Inorganic Chemical,Pharmacologic Substance]
   770   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   770   C0599638:WATER [Substance]
   770   C0681549:distilled [Occupational Activity]
   770   C1550678:Water [Inorganic Chemical]

Phrase: "which"

Phrase: "we"

Phrase: "designate as non-aged A1-40"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0001779:Aged [Organism Attribute]
   753   C0001792:Aged [Population Group]
   753   C0439509:/40 [Temporal Concept]
   753   C1518422:Non [Functional Concept]
   753   C1999167:aged [Population Group]

Phrase: "and"

Phrase: "non-aged A1-42,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0001779:Aged [Organism Attribute]
   812   C0001792:Aged [Population Group]
   812   C1518422:Non [Functional Concept]
   812   C1999167:aged [Population Group]

Phrase: "respectively."
Processing 00000000.tx.61: Non-aged A1-40 did not present any toxicity to septal cultures. 

Phrase: "Non-aged A1-40"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0001779:Aged [Organism Attribute]
   812   C0001792:Aged [Population Group]
   812   C0439509:/40 [Temporal Concept]
   812   C1518422:Non [Functional Concept]
   812   C1999167:aged [Population Group]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "any toxicity to septal cultures."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0040539:toxicity [Qualitative Concept]
   760   C0600688:Toxicity [Injury or Poisoning]
Processing 00000000.tx.62: Since soluble A1-42 is known to aggregate into insoluble, toxic amyloid fibrils more rapidly than A1-40 (28), we have examined the cytotoxicity of non-aged A1-42 at concentrations up to 10M. 

Phrase: "Since"

Phrase: "soluble A1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1749467:soluble [Cell Component]
   827   C1948047:Soluble [Qualitative Concept]

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "aggregate into insoluble, toxic amyloid fibrils more rapidly"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   770   C1449651:Amyloid Fibrils [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0205418:Aggregate [Qualitative Concept]
   744   C0225328:fibrils [Cell Component]
   744   C0600688:toxic [Injury or Poisoning]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1407029:Toxic [Qualitative Concept]
   744   C1637379:Rapidly [Qualitative Concept]
   711 E C1948066:Fibril [Physical Object]

Phrase: "than A1-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: "(28"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "have"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the cytotoxicity of non-aged A1-42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0596402:cytotoxicity [Cell or Molecular Dysfunction]

Phrase: "at concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0086045:Concentrations [Mental Process]
   966 E C1446561:Concentration [Quantitative Concept]
   916 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "up to 10M."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]
Processing 00000000.tx.63: Septal cultures treated with non-aged A1-42 at 10M for 24h (Fig. 1C) were morphologically indistinguishable from the control (Fig. 1A). 

Phrase: "Septal cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0010453:Cultures [Idea or Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]

Phrase: "treated with non-aged A1-42"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   753   C0001779:Aged [Organism Attribute]
   753   C0001792:Aged [Population Group]
   753   C1518422:Non [Functional Concept]
   753   C1522326:Treated [Functional Concept]
   753   C1999167:aged [Population Group]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "at 10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: "for 24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "(Fig. 1C"

Phrase: ")"

Phrase: "were"

Phrase: "morphologically indistinguishable from the control"

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.64: No difference was observed between the control culture and the culture treated with non-aged A1-42 for 48h (data not shown). 

Phrase: "No difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1705241:*Difference [Quantitative Concept]
  1000   C1705242:Difference [Qualitative Concept]
   928 E C0443199:Differential [Qualitative Concept]

Phrase: "was"

Phrase: "observed between the control culture"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0010453:Culture [Idea or Concept]
   760   C0220814:culture [Functional Concept]
   760   C0243148:control [Qualitative Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C1441672:Observed [Functional Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2242979:Culture [Laboratory Procedure]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "the culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "treated with non-aged A1-42"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   753   C0001779:Aged [Organism Attribute]
   753   C0001792:Aged [Population Group]
   753   C1518422:Non [Functional Concept]
   753   C1522326:Treated [Functional Concept]
   753   C1999167:aged [Population Group]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "for 48h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442464:48H [Temporal Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.65: The cellular ATP level was stable after non-aged A1-42 treatment for 12h (Fig. 1D), indicating that non-aged A1-42 at concentrations up to 10M did not disturb the energy metabolism in the culture. 

Phrase: "The cellular ATP level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "stable after non-aged A1-42 treatment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205360:Stable [Qualitative Concept]
   748   C1547311:Stable [Intellectual Product]

Phrase: "for 12h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456695:/12h [Temporal Concept]

Phrase: "(Fig. 1D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416886:1D [Gene or Genome]
   861   C1442449:1D [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that non-aged A1-42 at concentrations"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0001779:Aged [Organism Attribute]
   748   C0001792:Aged [Population Group]
   748   C0086045:Concentrations [Mental Process]
   748   C1518422:Non [Functional Concept]
   748   C1999167:aged [Population Group]
   714 E C1446561:Concentration [Quantitative Concept]

Phrase: "up to 10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "disturb"

Phrase: "the energy metabolism in the culture."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0014272:Energy Metabolism [Physiologic Function]
   753   C0025519:Metabolism [Organism Function]
   753   C0025520:metabolism [Functional Concept]
   753   C0424589:Energy [Finding]
   753   C0542479:Energy [Natural Phenomenon or Process]
   753   C1442080:Energy [Quantitative Concept]
Processing 00000000.tx.66: Histochemical staining for AChE, a marker enzyme of cholinergic neurons, revealed that cholinergic neurons were not affected by non-aged A1-42 treatment at 10M for 24h (Fig. 1, E and G). 

Phrase: "Histochemical staining for AChE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]

Phrase: "a marker enzyme of cholinergic neurons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0014442:Enzyme [Enzyme,Organic Chemical]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that cholinergic neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C2333949:Cholinergic Neurons [Cell]
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected by non-aged A1-42 treatment"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   748   C0001779:Aged [Organism Attribute]
   748   C0001792:Aged [Population Group]
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C0392760:Affected [Functional Concept]
   748   C1314939:Affected [Functional Concept]
   748   C1518422:Non [Functional Concept]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C1999167:aged [Population Group]
   748   C3538994:TREATMENT [Research Activity]
   714 E C0001721:Affect [Mental Process]

Phrase: "at 10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: "for 24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456696:/24h [Temporal Concept]
  1000   C1442770:24H [Temporal Concept]

Phrase: "(Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "E"

Phrase: "and"

Phrase: "G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.67: ChAT activity, another marker of cholinergic neurons, was not decreased by exposure of the neurons to non-aged A1-42 for 12h (Fig. 1H). 

Phrase: "ChAT activity,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1151953:choline acetyltransferase activity [Molecular Function]
   901   C1151922:acetyltransferase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0008407:Choline Acetyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1413376:CHOLINE ACETYLTRANSFERASE [Gene or Genome]

Phrase: "another marker of cholinergic neurons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0005516:Marker [Clinical Attribute]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "decreased by exposure of the neurons"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0027882:Neurons [Cell]
   753   C0205216:Decreased [Quantitative Concept]
   753   C0274281:Exposure, NOS [Injury or Poisoning]
   753   C0332157:Exposure [Clinical Attribute]
   753   C0392756:Decreased [Qualitative Concept]
   753   C0442797:decreased [Qualitative Concept]
   719 E C0547047:Decrease [Quantitative Concept]

Phrase: "to non-aged A1-42"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0001779:Aged [Organism Attribute]
   812   C0001792:Aged [Population Group]
   812   C1518422:Non [Functional Concept]
   812   C1999167:aged [Population Group]

Phrase: "for 12h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456695:/12h [Temporal Concept]

Phrase: "(Fig. 1H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442450:1H [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.68: Thus, non-aged A1-42 was not cytotoxic to cholinergic neurons in culture. 

Phrase: "Thus,"

Phrase: "non-aged A1-42"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0001779:Aged [Organism Attribute]
   812   C0001792:Aged [Population Group]
   812   C1518422:Non [Functional Concept]
   812   C1999167:aged [Population Group]

Phrase: "was"

Phrase: "not cytotoxic to cholinergic neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   760   C1511636:cytotoxic [Functional Concept]

Phrase: "in culture."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.69: These results suggest that neither non-aged A1-42 nor non-aged A1-40 used in our experiments formed toxic amyloid fibrils. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "neither non-aged A1-42"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0001779:Aged [Organism Attribute]
   812   C0001792:Aged [Population Group]
   812   C1518422:Non [Functional Concept]
   812   C1999167:aged [Population Group]

Phrase: "nor"

Phrase: "non-aged A1-40"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0001779:Aged [Organism Attribute]
   812   C0001792:Aged [Population Group]
   812   C0439509:/40 [Temporal Concept]
   812   C1518422:Non [Functional Concept]
   812   C1999167:aged [Population Group]

Phrase: "used in our experiments"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   770   C0681814:Experiments [Research Activity]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1706386:Experiment [Conceptual Entity]
   737 E C1947944:Use [Intellectual Product]

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "toxic amyloid fibrils."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1449651:Amyloid Fibrils [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0225328:fibrils [Cell Component]
   793 E C1948066:Fibril [Physical Object]
Processing 00000000.tx.70: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.71: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.72: Non-aged A1-42 is not neurotoxic. 

Phrase: "Non-aged A1-42"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0001779:Aged [Organism Attribute]
   812   C0001792:Aged [Population Group]
   812   C1518422:Non [Functional Concept]
   812   C1999167:aged [Population Group]

Phrase: "is"

Phrase: "not neurotoxic."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0235032:Neurotoxicity [Injury or Poisoning]
Processing 00000000.tx.73: A, B, and C, microscopic observation of primary septal cultures untreated (A) or treated either with aged A1-42 (10M) (B) or with non-aged A1-42 (10M) (C) for 24h. 

Phrase: "A,"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C,"

Phrase: "microscopic observation of primary septal cultures"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0369671:Microscopic observation [Laboratory Procedure]
   753   C0302523:Observation [Research Activity]
   753   C0700325:observation [Health Care Activity]
   753   C1964257:Observation [Diagnostic Procedure]

Phrase: "untreated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332155:untreated [Finding]

Phrase: "(A)"

Phrase: "or"

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "either with aged A1-42"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0001779:Aged [Organism Attribute]
   760   C0001792:Aged [Population Group]
   760   C1999167:aged [Population Group]

Phrase: "(10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "or with non-aged A1-42"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0001779:Aged [Organism Attribute]
   753   C0001792:Aged [Population Group]
   753   C1518422:Non [Functional Concept]
   753   C1999167:aged [Population Group]

Phrase: "(10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: "(C) for 24h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.74: D, non-aged A1-42 does not change the cellular ATP level. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "non-aged A1-42"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0001779:Aged [Organism Attribute]
   812   C0001792:Aged [Population Group]
   812   C1518422:Non [Functional Concept]
   812   C1999167:aged [Population Group]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "the cellular ATP level."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.75: Values are means of three determinationsS.D. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "means of three determinationsS.D."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C1704970:Means [Conceptual Entity]
   726 E C0444504:Mean [Quantitative Concept]
   726 E C2347634:Mean [Quantitative Concept]
   726 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.76: E, F, and G, cholinergic neurons in septal cultures untreated (E) or treated either with aged A1-42 (10M) (F) or with non-aged A1-42 (10M) (G) for 24h visualized by AChE cytochemistry. 

Phrase: "E,"

Phrase: "F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "cholinergic neurons in septal cultures"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C2333949:Cholinergic Neurons [Cell]
   760   C0027882:Neurons [Cell]

Phrase: "untreated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332155:untreated [Finding]

Phrase: "(E)"

Phrase: "or"

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "either with aged A1-42"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0001779:Aged [Organism Attribute]
   760   C0001792:Aged [Population Group]
   760   C1999167:aged [Population Group]

Phrase: "(10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: "(F)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "or with non-aged A1-42"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0001779:Aged [Organism Attribute]
   753   C0001792:Aged [Population Group]
   753   C1518422:Non [Functional Concept]
   753   C1999167:aged [Population Group]

Phrase: "(10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: "(G) for 24h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0439417:g/24h [Quantitative Concept]
   790   C0439267:g% [Quantitative Concept]

Phrase: "visualized by AChE cytochemistry."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0001044:Acetylcholine esterase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   760   C0010741:Cytochemistry [Biomedical Occupation or Discipline]
   760   C0014894:Esterase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0234621:Visualized [Functional Concept]
Processing 00000000.tx.77: H, cholinergic neuronal marker, ChAT activity, shows no change on non-aged A1-42 treatment. 

Phrase: "H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "cholinergic neuronal marker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005516:Marker [Clinical Attribute]

Phrase: "ChAT activity,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1151953:choline acetyltransferase activity [Molecular Function]
   901   C1151922:acetyltransferase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0008407:Choline Acetyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1413376:CHOLINE ACETYLTRANSFERASE [Gene or Genome]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "no change on non-aged A1-42 treatment."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0442739:No change [Finding]
   770   C1548568:No change [Intellectual Product]
   744   C0392747:Change [Functional Concept]
   744   C0443172:change [Quantitative Concept]
   744   C1705241:Change [Quantitative Concept]
Processing 00000000.tx.78: Values are means of three determinationsS.D. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "means of three determinationsS.D."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C1704970:Means [Conceptual Entity]
   726 E C0444504:Mean [Quantitative Concept]
   726 E C2347634:Mean [Quantitative Concept]
   726 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.79: [View Larger Version of this Image (71K GIF file)] Non-aged A1-42 Suppressed ACh Synthesis in the Culture, Non-aged A1-40 Did Not Primary septal cultures were treated with either non-aged A1-40 or non-aged A1-42 for 12h, and the intracellular ACh level was determined by means of HPLC with an electrochemical detector system (1, 22). 

Phrase: "[View Larger Version of this Image"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "(71K GIF file"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016094:File [Occupational Activity]
   827   C0180853:File [Medical Device]
   827   C1522646:File [Functional Concept]

Phrase: ")"

Phrase: "] Non-aged A1-42 Suppressed ACh Synthesis in the Culture,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1154432:acetylcholine synthesis [Molecular Function]
   739   C0220781:synthesis [Biologic Function]
   739   C1883254:Synthesis [Activity]

Phrase: "Non-aged A1-40"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0001779:Aged [Organism Attribute]
   812   C0001792:Aged [Population Group]
   812   C0439509:/40 [Temporal Concept]
   812   C1518422:Non [Functional Concept]
   812   C1999167:aged [Population Group]

Phrase: "Did"

Phrase: "Not Primary septal cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0010453:Cultures [Idea or Concept]
   779 E C0220814:culture [Functional Concept]
   779 E C0430400:Culture [Laboratory Procedure]
   779 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "treated with either non-aged A1-40"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   778   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   748   C0001779:Aged [Organism Attribute]
   748   C0001792:Aged [Population Group]
   748   C0439509:/40 [Temporal Concept]
   748   C1518422:Non [Functional Concept]
   748   C1522326:Treated [Functional Concept]
   748   C1999167:aged [Population Group]
   714 E C1292734:TREAT [Functional Concept]

Phrase: "or"

Phrase: "non-aged A1-42 for 12h,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0001779:Aged [Organism Attribute]
   753   C0001792:Aged [Population Group]
   753   C0456695:/12h [Temporal Concept]
   753   C1518422:Non [Functional Concept]
   753   C1999167:aged [Population Group]

Phrase: "and"

Phrase: "the intracellular ACh level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "determined by means of HPLC"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C1704970:Means [Conceptual Entity]
   726 E C0444504:Mean [Quantitative Concept]
   726 E C2347634:Mean [Quantitative Concept]
   726 E C2348143:Mean [Quantitative Concept]

Phrase: "with an electrochemical detector system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "22"

Phrase: ")."
Processing 00000000.tx.80: Non-aged A1-42 at a saturating concentration of 100nM reduced the intracellular ACh level to ~40% of the control after a 12-h treatment, whereas non-aged A1-40 was ineffective (Fig. 2A). 

Phrase: "Non-aged A1-42 at a saturating concentration of 100nM"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   739   C0001779:Aged [Organism Attribute]
   739   C0001792:Aged [Population Group]
   739   C0086045:Concentration [Mental Process]
   739   C0522534:saturating [Phenomenon or Process]
   739   C1446561:Concentration [Quantitative Concept]
   739   C1518422:Non [Functional Concept]
   739   C1999167:aged [Population Group]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the intracellular ACh level to ~40% of the control"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   742   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   742   C0175996:intracellular [Cell Component]
   742   C0178719:Intracellular [Spatial Concept]
   742   C0243148:control [Qualitative Concept]
   742   C0439509:/40 [Temporal Concept]
   742   C0441889:Level [Qualitative Concept]
   742   C0456079:Level [Classification]
   742   C1547707:Level [Geographic Area]
   742   C1550141:Control [Substance]
   742   C1882979:Control [Conceptual Entity]
   742   C2587213:Control [Functional Concept]
   742   C2946261:Level [Pharmacologic Substance]
   742   C3274648:Control [Qualitative Concept]

Phrase: "after a 12-h treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "whereas"

Phrase: "non-aged A1-40"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0001779:Aged [Organism Attribute]
   812   C0001792:Aged [Population Group]
   812   C0439509:/40 [Temporal Concept]
   812   C1518422:Non [Functional Concept]
   812   C1999167:aged [Population Group]

Phrase: "was"

Phrase: "ineffective"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3242229:ineffective [Idea or Concept]

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.81: Since neither non-aged A1-40 nor non-aged A1-42 was neurotoxic, cholinergic neuronal loss cannot be the cause of the reduced ACh level. 

Phrase: "Since"

Phrase: "neither non-aged A1-40"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0001779:Aged [Organism Attribute]
   812   C0001792:Aged [Population Group]
   812   C0439509:/40 [Temporal Concept]
   812   C1518422:Non [Functional Concept]
   812   C1999167:aged [Population Group]

Phrase: "nor"

Phrase: "non-aged A1-42"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0001779:Aged [Organism Attribute]
   812   C0001792:Aged [Population Group]
   812   C1518422:Non [Functional Concept]
   812   C1999167:aged [Population Group]

Phrase: "was"

Phrase: "neurotoxic, cholinergic neuronal loss"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1850496:Neuronal loss [Finding]
   825 E C0598940:neuron loss [Finding]
   812   C1517945:Loss [Quantitative Concept]

Phrase: "cannot"

Phrase: "be"

Phrase: "the cause of the reduced ACh level."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0015127:cause [Functional Concept]
   748   C1524003:Cause [Conceptual Entity]
Processing 00000000.tx.82: Therefore, the decline in the intracellular ACh level results either from reduced ACh synthesis or from accelerated ACh release. 

Phrase: "Therefore,"

Phrase: "the decline in the intracellular ACh level results either"

Phrase: "from reduced ACh synthesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1154432:acetylcholine synthesis [Molecular Function]
   827   C0220781:synthesis [Biologic Function]
   827   C1883254:Synthesis [Activity]

Phrase: "or from accelerated ACh release."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0521110:Accelerated [Functional Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.83: Non-aged A1-42 at 10nM caused a significant reduction in the intracellular ACh level (Fig. 2A). 

Phrase: "Non-aged A1-42 at 10nM"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0001779:Aged [Organism Attribute]
   753   C0001792:Aged [Population Group]
   753   C1518422:Non [Functional Concept]
   753   C1999167:aged [Population Group]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a significant reduction in the intracellular ACh level"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0301630:Reduction [Natural Phenomenon or Process]
   744   C0392756:Reduction [Qualitative Concept]
   744   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.84: A corresponding reduction was induced in the synthesis rate of ACh from pyruvate by treatment with non-aged A1-42 at 10nM for 12h (Fig. 2B). 

Phrase: "A corresponding reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0301630:Reduction [Natural Phenomenon or Process]
   861   C0392756:Reduction [Qualitative Concept]
   861   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "induced in the synthesis rate of ACh"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C1154432:acetylcholine synthesis [Molecular Function]
   748   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   748   C0205263:Induced [Functional Concept]
   748   C0220781:synthesis [Biologic Function]
   748   C0871208:Rate [Activity]
   748   C1521828:Rate [Quantitative Concept]
   748   C1883254:Synthesis [Activity]

Phrase: "from pyruvate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034354:pyruvate [Organic Chemical]
  1000   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: "by treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "with non-aged A1-42"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0001779:Aged [Organism Attribute]
   812   C0001792:Aged [Population Group]
   812   C1518422:Non [Functional Concept]
   812   C1999167:aged [Population Group]

Phrase: "at 10nM"

Phrase: "for 12h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456695:/12h [Temporal Concept]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.85: Thus, reduced ACh synthesis is primarily responsible for the decline in the intracellular ACh level after non-aged A1-42 treatment. 

Phrase: "Thus,"

Phrase: "reduced ACh synthesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1154432:acetylcholine synthesis [Molecular Function]
   827   C0220781:synthesis [Biologic Function]
   827   C1883254:Synthesis [Activity]

Phrase: "is"

Phrase: "primarily responsible for the decline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "in the intracellular ACh level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]

Phrase: "after non-aged A1-42 treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0039798:treatment [Functional Concept]
   804   C0087111:Treatment [Therapeutic or Preventive Procedure]
   804   C1522326:Treatment [Functional Concept]
   804   C1533734:Treatment [Therapeutic or Preventive Procedure]
   804   C1705169:Treatment [Conceptual Entity]
   804   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.86: Treatment of non-aged A1-42 at zero time affected neither the intracellular ACh level nor the ACh synthesis rate. 

Phrase: "Treatment of non-aged A1-42"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "at zero time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "neither the intracellular ACh level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]

Phrase: "nor"

Phrase: "the ACh synthesis rate."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]
   734   C1154432:acetylcholine synthesis [Molecular Function]
Processing 00000000.tx.87: The results suggest A1-42 remaining in the cell lysate has no direct effect on the assay procedures, but non-aged A1-42 works on the living neurons to disturb the ACh synthesis. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "A1-42 remaining in the cell lysate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1527428:Remaining [Qualitative Concept]

Phrase: "has"

Phrase: "no direct effect on the assay procedures,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1301751:No effect [Qualitative Concept]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "but"

Phrase: "non-aged A1-42 works on the living neurons to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0043227:works [Occupational Activity]

Phrase: "disturb"

Phrase: "the ACh synthesis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1154432:acetylcholine synthesis [Molecular Function]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]
Processing 00000000.tx.88: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.89: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.90: Suppression of ACh synthesis in cholinergic neurons by physiological concentrations of non-aged A1-42. 

Phrase: "Suppression of ACh synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0221103:Suppression [Pathologic Function]
   770   C0301625:Suppression [Organism Function]
   770   C0439181:% suppression [Quantitative Concept]
   770   C0728721:suppression [Mental Process]

Phrase: "in cholinergic neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C2333949:Cholinergic Neurons [Cell]
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "by physiological concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of non-aged A1-42."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0001779:Aged [Organism Attribute]
   812   C0001792:Aged [Population Group]
   812   C1518422:Non [Functional Concept]
   812   C1999167:aged [Population Group]
Processing 00000000.tx.91: A, primary septal cultures were treated with various concentrations of either non-aged A1-42 () or non-aged A1-40 () for 12 h, and intracellular ACh was determined by using an HPLC-electrochemical detector system. 

Phrase: "A,"

Phrase: "primary septal cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0010453:Cultures [Idea or Concept]
   793 E C0220814:culture [Functional Concept]
   793 E C0430400:Culture [Laboratory Procedure]
   793 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "treated with various concentrations of either non-aged A1-42"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   760   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   739   C0001779:Aged [Organism Attribute]
   739   C0001792:Aged [Population Group]
   739   C0086045:Concentrations [Mental Process]
   739   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   739   C1518422:Non [Functional Concept]
   739   C1522326:Treated [Functional Concept]
   739   C1999167:aged [Population Group]
   706 E C1292734:TREAT [Functional Concept]
   706 E C1446561:Concentration [Quantitative Concept]

Phrase: "("

Phrase: ")"

Phrase: "or"

Phrase: "non-aged A1-40"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0001779:Aged [Organism Attribute]
   812   C0001792:Aged [Population Group]
   812   C0439509:/40 [Temporal Concept]
   812   C1518422:Non [Functional Concept]
   812   C1999167:aged [Population Group]

Phrase: "("

Phrase: ")"

Phrase: "for 12 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "intracellular ACh"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "determined by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an HPLC-electrochemical detector system."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.92: B, after a 12-h incubation of cultures with non-aged A1-42, the ACh synthesis rate was determined by measuring transfer of radioactivity from [2-14C]pyruvate per min. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "after"

Phrase: "a 12-h incubation of cultures"

Phrase: "with non-aged A1-42,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0001779:Aged [Organism Attribute]
   812   C0001792:Aged [Population Group]
   812   C1518422:Non [Functional Concept]
   812   C1999167:aged [Population Group]

Phrase: "the ACh synthesis rate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]
   734   C1154432:acetylcholine synthesis [Molecular Function]

Phrase: "was"

Phrase: "determined by measuring transfer of radioactivity"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0034553:Radioactivity [Natural Phenomenon or Process]
   753   C0040671:Transfer [Mental Process]
   753   C0444706:measuring [Qualitative Concept]
   753   C0449770:measuring [Quantitative Concept]
   753   C1705822:Transfer [Activity]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]

Phrase: "from"

Phrase: "[2-14C"

Phrase: "]pyruvate per min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034354:pyruvate [Organic Chemical]
   790   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]
Processing 00000000.tx.93: Values are means of three determinations S.D. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "means of three determinations S.D."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C1704970:Means [Conceptual Entity]
   719 E C0444504:Mean [Quantitative Concept]
   719 E C2347634:Mean [Quantitative Concept]
   719 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.94: [View Larger Version of this Image (19K GIF file)] Suppression of ACh Synthesis Can Be Attributed to Reduced Mitochondrial PDH Activity, Probably via TPKI/GSK-3 Activation by Non-aged A1-42 ACh is synthesized from choline and acetyl-CoA by ChAT, which is not rate-limiting under normal conditions (29). 

Phrase: "[View Larger Version of this Image"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "(19K GIF file"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016094:File [Occupational Activity]
   827   C0180853:File [Medical Device]
   827   C1522646:File [Functional Concept]

Phrase: ")"

Phrase: "] Suppression of ACh Synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0221103:Suppression [Pathologic Function]
   770   C0301625:Suppression [Organism Function]
   770   C0439181:% suppression [Quantitative Concept]
   770   C0728721:suppression [Mental Process]

Phrase: "Can"

Phrase: "Be"

Phrase: "Attributed to Reduced Mitochondrial PDH Activity,"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   814   C1151688:pyruvate dehydrogenase activity [Molecular Function]
   778   C0034343:pyruvate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   774   C0086439:Reduced Activity [Sign or Symptom]
   757   C1879549:Activity Attribute [Qualitative Concept]
   748   C0026237:Mitochondrial [Cell Component]
   748   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0034354:pyruvate [Organic Chemical]
   748   C0205177:Activity [Functional Concept]
   748   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]
   748   C0392756:Reduced [Qualitative Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C0521451:Mitochondrial [Functional Concept]
   748   C1561536:*Activity [Idea or Concept]
   714   C0449234:Attribute [Idea or Concept]
   714   C1704772:Attribute [Conceptual Entity]
   714   C1882133:Attribute [Qualitative Concept]

Phrase: "Probably via TPKI/GSK-3 Activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0244989:GSK-3 [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0750492:Probably [Idea or Concept]
   753   C1325174:GSK [Molecular Function]
   753   C1879547:Activation [Activity]

Phrase: "by Non-aged A1-42 ACh"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "synthesized from choline"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0008405:Choline [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   790   C1883254:Synthesized [Activity]

Phrase: "and"

Phrase: "acetyl-CoA by ChAT,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   844   C0001019:Acetyl-CoA Acetyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0001026:Acetyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "which"

Phrase: "is"

Phrase: "not rate-limiting under normal conditions"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   767   C0442816:normal limit [Quantitative Concept]
   767   C1265570:normal limit [Finding]
   753   C0439801:limiting [Functional Concept]
   753   C0871208:Rate [Activity]
   753   C1521828:Rate [Quantitative Concept]
   719 E C1549649:Limit [Idea or Concept]
   719 E C2349209:Limit [Conceptual Entity]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.95: Treatment with non-aged A1-42 for 12h did not change ChAT activity (Figs. 1H and 3A). 

Phrase: "Treatment with non-aged A1-42"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "for 12h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456695:/12h [Temporal Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "ChAT activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1151953:choline acetyltransferase activity [Molecular Function]
   901   C1151922:acetyltransferase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0008407:Choline Acetyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1413376:CHOLINE ACETYLTRANSFERASE [Gene or Genome]

Phrase: "(Figs. 1H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442450:1H [Temporal Concept]

Phrase: "and"

Phrase: "3A"

Phrase: ")."
Processing 00000000.tx.96: Therefore, a reduced supply of either choline or acetyl-CoA accounts for the decline in ACh synthesis. 

Phrase: "Therefore,"

Phrase: "a reduced supply of either choline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0243163:supply [Idea or Concept]
   753   C0699914:supply [Quantitative Concept]
   753   C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
   753   C1561604:supply [Functional Concept]
   753   C1875802:SUPPLY [Medical Device]
   753   C1999230:Supply [Activity]

Phrase: "or"

Phrase: "acetyl-CoA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001026:Acetyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "accounts for the decline"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1551359:account [Idea or Concept]
   770   C2741673:Account # [Clinical Attribute]
   770   C2981730:Account [Classification]

Phrase: "in ACh synthesis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1154432:acetylcholine synthesis [Molecular Function]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]
Processing 00000000.tx.97: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.98: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.99: Inhibition of ACh synthesis by non-aged A1-42 is attributed to a reduction in PDH activity, not a reduction in ChAT activity, AChE activity, or choline uptake. 

Phrase: "Inhibition of ACh synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "by non-aged A1-42"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0001779:Aged [Organism Attribute]
   812   C0001792:Aged [Population Group]
   812   C1518422:Non [Functional Concept]
   812   C1999167:aged [Population Group]

Phrase: "is"

Phrase: "attributed to a reduction"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0301630:Reduction [Natural Phenomenon or Process]
   770   C0392756:Reduction [Qualitative Concept]
   770   C0441610:Reduction [Therapeutic or Preventive Procedure]
   737   C0449234:Attribute [Idea or Concept]
   737   C1704772:Attribute [Conceptual Entity]
   737   C1882133:Attribute [Qualitative Concept]

Phrase: "in PDH activity,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1151688:pyruvate dehydrogenase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0034343:pyruvate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a reduction in ChAT activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C2267000:Reduction Activity [Molecular Function]
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "AChE activity,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1149827:acetylcholinesterase activity [Molecular Function]
   901   C1149811:esterase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0001044:Acetylcholine esterase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "choline uptake."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]
Processing 00000000.tx.100: A, after a 12-h incubation of cultures with non-aged A1-42, ChAT activity (), AChE activity (), or choline uptake () was determined. 

Phrase: "A,"

Phrase: "after"

Phrase: "a 12-h incubation of cultures"

Phrase: "with non-aged A1-42,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0001779:Aged [Organism Attribute]
   812   C0001792:Aged [Population Group]
   812   C1518422:Non [Functional Concept]
   812   C1999167:aged [Population Group]

Phrase: "ChAT activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1151953:choline acetyltransferase activity [Molecular Function]
   901   C1151922:acetyltransferase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0008407:Choline Acetyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1413376:CHOLINE ACETYLTRANSFERASE [Gene or Genome]

Phrase: "("

Phrase: ")"

Phrase: ","

Phrase: "AChE activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1149827:acetylcholinesterase activity [Molecular Function]
   901   C1149811:esterase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0001044:Acetylcholine esterase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "("

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "choline uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]

Phrase: "("

Phrase: ")"

Phrase: "was"

Phrase: "determined."
Processing 00000000.tx.101: B, after a 12-h incubation of cultures with non-aged A1-42, PDH activity () or TPKI/GSK-3 activity () was determined. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "after"

Phrase: "a 12-h incubation of cultures"

Phrase: "with non-aged A1-42,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0001779:Aged [Organism Attribute]
   812   C0001792:Aged [Population Group]
   812   C1518422:Non [Functional Concept]
   812   C1999167:aged [Population Group]

Phrase: "PDH activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1151688:pyruvate dehydrogenase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0034343:pyruvate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "("

Phrase: ")"

Phrase: "or"

Phrase: "TPKI/GSK-3 activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "("

Phrase: ")"

Phrase: "was"

Phrase: "determined."
Processing 00000000.tx.102: Values are means of three determinationsS.D. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "means of three determinationsS.D."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C1704970:Means [Conceptual Entity]
   726 E C0444504:Mean [Quantitative Concept]
   726 E C2347634:Mean [Quantitative Concept]
   726 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.103: [View Larger Version of this Image (19K GIF file)] Neurons obtain choline mainly from the diet using a specialized transporter system that also salvages free choline generated from ACh released intrasynaptically by AChE (30). 

Phrase: "[View Larger Version of this Image"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333052:Version [Functional Concept]
   753   C2607870:Version [Spatial Concept]

Phrase: "(19K GIF file"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016094:File [Occupational Activity]
   827   C0180853:File [Medical Device]
   827   C1522646:File [Functional Concept]

Phrase: ")"

Phrase: "] Neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "choline mainly from the diet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0008405:Choline [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a specialized transporter system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "that also salvages free choline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0008405:Choline [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "generated from ACh"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   790   C3146294:Generated [Activity]

Phrase: "released"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0391871:Released [Functional Concept]
  1000   C1283071:Released [Functional Concept]
   966 E C0030685:Release [Health Care Activity]
   966 E C0439180:% release [Quantitative Concept]
   966 E C0680255:release [Health Care Activity]
   966 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "intrasynaptically by AChE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0001044:Acetylcholine esterase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   770   C0014894:Esterase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.104: Treatment with non-aged A1-42 did not interfere with this choline uptake system, since we found no statistically significant change in the choline uptake in the case of non-aged A1-42 treatment (Fig. 3A). 

Phrase: "Treatment with non-aged A1-42"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "interfere with this choline uptake system,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0008405:Choline [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   753   C0243144:Uptake [Physiologic Function]
   753   C0347980:% uptake [Quantitative Concept]
   753   C0449913:System [Functional Concept]
   753   C0521102:Interfere [Qualitative Concept]
   753   C1553451:System [Manufactured Object]
   753   C1704459:System [Medical Device]

Phrase: "since"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no statistically significant change in the choline uptake"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0442739:No change [Finding]
   767   C1548568:No change [Intellectual Product]
   744   C0392747:Change [Functional Concept]
   744   C0443172:change [Quantitative Concept]
   744   C1705241:Change [Quantitative Concept]

Phrase: "in the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of non-aged A1-42 treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0039798:treatment [Functional Concept]
   804   C0087111:Treatment [Therapeutic or Preventive Procedure]
   804   C1522326:Treatment [Functional Concept]
   804   C1533734:Treatment [Therapeutic or Preventive Procedure]
   804   C1705169:Treatment [Conceptual Entity]
   804   C3538994:TREATMENT [Research Activity]

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.105: In accordance with AChE cytochemistry (Fig. 1, E and G), AChE activity was stable after non-aged A1-42 treatment for 12h (Fig. 3A). 

Phrase: "In accordance with AChE cytochemistry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0010741:Cytochemistry [Biomedical Occupation or Discipline]
   734   C0001044:Acetylcholine esterase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "E"

Phrase: "and"

Phrase: "G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "AChE activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1149827:acetylcholinesterase activity [Molecular Function]
   901   C1149811:esterase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0001044:Acetylcholine esterase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "stable after non-aged A1-42 treatment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205360:Stable [Qualitative Concept]
   748   C1547311:Stable [Intellectual Product]

Phrase: "for 12h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456695:/12h [Temporal Concept]

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.106: These results suggest that non-aged A1-42 did not influence choline turnover in cholinergic neurons. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that non-aged A1-42"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0001779:Aged [Organism Attribute]
   812   C0001792:Aged [Population Group]
   812   C1518422:Non [Functional Concept]
   812   C1999167:aged [Population Group]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "influence"

Phrase: "choline turnover in cholinergic neurons."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0031227:turnover [Quantitative Concept]
   760   C0243127:turnover [Functional Concept]
   760   C0443331:Turnover [Health Care Activity]
Processing 00000000.tx.107: This implies that a reduced supply of acetyl-CoA from pyruvate must be critical (Fig. 2B). 

Phrase: "This"

Phrase: "implies"

Phrase: "that"

Phrase: "a reduced supply of acetyl-CoA"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0243163:supply [Idea or Concept]
   753   C0699914:supply [Quantitative Concept]
   753   C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
   753   C1561604:supply [Functional Concept]
   753   C1875802:SUPPLY [Medical Device]
   753   C1999230:Supply [Activity]

Phrase: "from pyruvate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034354:pyruvate [Organic Chemical]
  1000   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: "must"

Phrase: "be"

Phrase: "critical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511545:Critical [Qualitative Concept]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.108: In adult mammalian brain, acetyl-CoA is mainly produced by oxidative decarboxylation of pyruvate by mitochondrial PDH complex. 

Phrase: "In adult mammalian brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "acetyl-CoA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001026:Acetyl CoA [Biologically Active Substance,Lipid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "mainly"

Phrase: "produced by oxidative decarboxylation of pyruvate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0011094:Decarboxylation [Natural Phenomenon or Process]
   753   C0034354:pyruvate [Organic Chemical]
   753   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]
   753   C0311404:Oxidative [Functional Concept]

Phrase: "by mitochondrial PDH complex."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1523385:mitochondrial pyruvate dehydrogenase complex [Cell Component]
   923   C0034344:Pyruvate Dehydrogenase Complex [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1167289:pyruvate dehydrogenase complex [Cell Component]
   861   C0034343:pyruvate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2755851:dehydrogenase complex [Cell Component]
   812   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0034354:pyruvate [Organic Chemical]
   812   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.109: Non-aged A1-42 at a saturating concentration of 100nM reduced PDH activity to ~30% of the control (Fig. 3B), which corresponds well with the dose-dependent reductions of the intracellular ACh level (Fig. 2A) and ACh synthesis rate (Fig. 2B). 

Phrase: "Non-aged A1-42 at a saturating concentration of 100nM"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   739   C0001779:Aged [Organism Attribute]
   739   C0001792:Aged [Population Group]
   739   C0086045:Concentration [Mental Process]
   739   C0522534:saturating [Phenomenon or Process]
   739   C1446561:Concentration [Quantitative Concept]
   739   C1518422:Non [Functional Concept]
   739   C1999167:aged [Population Group]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "PDH activity to ~30% of the control"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   800   C1151688:pyruvate dehydrogenase activity [Molecular Function]
   770   C0034343:pyruvate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0034354:pyruvate [Organic Chemical]
   744   C0205177:Activity [Functional Concept]
   744   C0243148:control [Qualitative Concept]
   744   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1550141:Control [Substance]
   744   C1561536:*Activity [Idea or Concept]
   744   C1882979:Control [Conceptual Entity]
   744   C2587213:Control [Functional Concept]
   744   C3274648:Control [Qualitative Concept]
   731   C1706449:Active Control [Research Activity]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "corresponds"

Phrase: "well with the dose-dependent reductions of the intracellular ACh level"
Meta Candidates (Total=20; Excluded=1; Pruned=0; Remaining=19)
   756   C1512045:Dose-dependent [Quantitative Concept]
   754   C0178602:Dose Level [Quantitative Concept]
           Dose
   738   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   738   C0175996:intracellular [Cell Component]
   738   C0178719:Intracellular [Spatial Concept]
   738   C0205170:Well [Qualitative Concept]
   738   C0301630:reductions [Natural Phenomenon or Process]
   738   C0441610:reductions [Therapeutic or Preventive Procedure]
   738   C0441889:Level [Qualitative Concept]
   738   C0456079:Level [Classification]
   738   C0851827:Dependent [Qualitative Concept]
   738   C0869039:Dose [Quantitative Concept]
   738   C1114758:Dose # [Clinical Attribute]
   738   C1547707:Level [Geographic Area]
   738   C1701901:Dependent [Qualitative Concept]
   738   C2946261:Level [Pharmacologic Substance]
   738   C3146287:Well [Manufactured Object]
   738   C3244310:dependent [Functional Concept]
   704 E C0392756:Reduction [Qualitative Concept]

Phrase: "(Fig. 2A"

Phrase: ")"

Phrase: "and"

Phrase: "ACh synthesis rate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]
   734   C1154432:acetylcholine synthesis [Molecular Function]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.110: Non-aged A1-42 treatment for 3h was enough to cause maximal inhibition of PDH activity in the culture. 

Phrase: "Non-aged A1-42 treatment for 3h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]

Phrase: "was"

Phrase: "enough to"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "maximal inhibition of PDH activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "in the culture."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.111: Correspondingly, the intracellular ACh reached the lowest level after non-aged A1-42 exposure for 3h. 

Phrase: "Correspondingly,"

Phrase: "the intracellular ACh"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "reached"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2584321:Reach [Organism Function]

Phrase: "the lowest level after non-aged A1-42 exposure"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0441889:Level [Qualitative Concept]
   742   C0456079:Level [Classification]
   742   C1547707:Level [Geographic Area]
   742   C2946261:Level [Pharmacologic Substance]

Phrase: "for 3h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]
Processing 00000000.tx.112: Thus, it appears that non-aged A1-42 suppressed ACh synthesis mainly by inhibiting PDH activity and so reducing the availability of acetyl-CoA. 

Phrase: "Thus,"

Phrase: "it"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "that non-aged A1-42 suppressed ACh synthesis mainly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1154432:acetylcholine synthesis [Molecular Function]
   793   C0220781:synthesis [Biologic Function]
   793   C1883254:Synthesis [Activity]

Phrase: "by inhibiting PDH activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1151688:pyruvate dehydrogenase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "reducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reducing [Qualitative Concept]

Phrase: "the availability of acetyl-CoA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0470187:Availability of [Functional Concept]
           Availability
Processing 00000000.tx.113: PDH activity is regulated by phosphorylation (31, 32). 

Phrase: "PDH activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1151688:pyruvate dehydrogenase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0034343:pyruvate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "regulated by phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C0851285:Regulated [Governmental or Regulatory Activity]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "(31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "32"

Phrase: ")."
Processing 00000000.tx.114: We have previously found that PDH is phosphorylated and inactivated by TPKI/GSK-3 in vitro as well as in A25-35-treated hippocampal neurons (1). 

Phrase: "We"

Phrase: "have"

Phrase: "previously"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that PDH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0034343:pyruvate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0034354:pyruvate [Organic Chemical]
   861   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: "is"

Phrase: "phosphorylated"

Phrase: "and"

Phrase: "inactivated by TPKI/GSK-3 in vitro"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0021135:In Vitro [Intellectual Product]
   778   C0244989:GSK-3 [Amino Acid, Peptide, or Protein,Enzyme]
   778   C1533691:in vitro [Qualitative Concept]
           vitro
   778   C2827718:In Vitro [Functional Concept]
   748   C1325174:GSK [Molecular Function]

Phrase: "as well as in A25-35-treated hippocampal neurons"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   742   C0019564:Hippocampal [Body Part, Organ, or Organ Component]
   742   C0027882:Neurons [Cell]
   742   C0205170:Well [Qualitative Concept]
   742   C0332293:treated [Therapeutic or Preventive Procedure]
   742   C1522326:Treated [Functional Concept]
   742   C3146287:Well [Manufactured Object]
   708 E C1292734:TREAT [Functional Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.115: In septal cultures, 10nM A1-42 was enough to activate mitochondrial TPKI/GSK-3 by 2-fold (Fig. 3B). 

Phrase: "In septal cultures,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0010453:Cultures [Idea or Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]

Phrase: "10nM A1-42"

Phrase: "was"

Phrase: "enough to"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "mitochondrial TPKI/GSK-3 by 2-fold"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0244989:GSK-3 [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0026237:Mitochondrial [Cell Component]
   748   C0332462:Fold [Spatial Concept]
   748   C0521451:Mitochondrial [Functional Concept]
   748   C1325174:GSK [Molecular Function]
   748   C1880834:FOLD [Phenomenon or Process]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.116: These results suggest that TPKI/GSK-3 is the main mediator of the inactivation of PDH by non-aged A1-42 in cholinergic neurons, as previously found in hippocampal neurons. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that TPKI/GSK-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0244989:GSK-3 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1325174:GSK [Molecular Function]

Phrase: "is"

Phrase: "the main mediator of the inactivation of PDH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "by non-aged A1-42"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0001779:Aged [Organism Attribute]
   812   C0001792:Aged [Population Group]
   812   C1518422:Non [Functional Concept]
   812   C1999167:aged [Population Group]

Phrase: "in cholinergic neurons,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C2333949:Cholinergic Neurons [Cell]
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "as"

Phrase: "previously"

Phrase: "found in hippocampal neurons."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0019564:Hippocampal [Body Part, Organ, or Organ Component]
   770   C0027882:Neurons [Cell]
   770   C0150312:Found [Quantitative Concept]
   737 E C0243095:Find [Finding]
Processing 00000000.tx.117: DISCUSSION A1-42, a minor species in normal APP metabolism, is highly aggregable (28), acts as a seed for amyloid fibrils (33), and seems to deposit initially in amyloid plaques in AD (34) and Down's syndrome (DS) (35). 

Phrase: "DISCUSSION A1-42,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "a minor species in normal APP metabolism,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1705920:Species [Conceptual Entity]

Phrase: "is"

Phrase: "highly aggregable"

Phrase: "(28"

Phrase: ")"

Phrase: ","

Phrase: "acts as a seed"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0036563:Seed [Plant]
   770   C0079613:ACT [Therapeutic or Preventive Procedure]
   770   C1705192:Seed [Laboratory Procedure]
   770   C1882540:{Seed} [Quantitative Concept]
   770   C2346495:Seed [Conceptual Entity]
   715 E C1519232:Seminal [Clinical Attribute]

Phrase: "for amyloid fibrils"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1449651:Amyloid Fibrils [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0225328:fibrils [Cell Component]
   827 E C1948066:Fibril [Physical Object]

Phrase: "(33"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "seems"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "deposit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333562:Deposit [Functional Concept]

Phrase: "initially in amyloid plaques"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
   833   C2936349:Plaques, Amyloid [Acquired Abnormality]
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0205265:Initially [Temporal Concept]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737 E C0011389:Plaque [Disease or Syndrome]
   737 E C0332461:Plaque [Finding]

Phrase: "in AD (34"

Phrase: ")"

Phrase: "and"

Phrase: "Down's syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "(DS) (35"

Phrase: ")."
Processing 00000000.tx.118: APP mutation linked to familial AD (FAD) or an increased APP gene dosage in DS brain leads to a specific increase in A1-42 production (19, 36). 

Phrase: "APP mutation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0026882:Mutation [Genetic Function]
   812   C1705285:Mutation [Cell or Molecular Dysfunction]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "linked to familial AD (FAD)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0015576:familial [Family Group]
   770   C0241888:Familial [Functional Concept]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "or"

Phrase: "an increased APP gene dosage in DS brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0178655:Gene Dosage [Quantitative Concept]
   739   C0178602:Dosage [Quantitative Concept]

Phrase: "leads to a specific increase"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0181586:leads [Medical Device]
   760   C0205369:Specific [Qualitative Concept]
   760   C0442805:Increase [Functional Concept]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C1552740:specific [Intellectual Product]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in A1-42 production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033268:production [Occupational Activity]

Phrase: "(19,"

Phrase: "36"

Phrase: ")."
Processing 00000000.tx.119: Recently, Younkin and colleagues reported that mutations in FAD genes, including presenilin 1(37) and presenilin 2(38), result in increased levels of A1-42 in fibroblasts and plasma in some FAD kindreds (39). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "Younkin"

Phrase: "and"

Phrase: "colleagues"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that mutations in FAD genes,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C0596611:gene mutations [Genetic Function]
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "presenilin 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(37"

Phrase: ")"

Phrase: "and"

Phrase: "presenilin 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(38"

Phrase: ")"

Phrase: ","

Phrase: "result in increased levels of A1-42"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C2825142:Result [Finding]

Phrase: "in fibroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016030:Fibroblasts [Cell]

Phrase: "and"

Phrase: "plasma in some FAD kindreds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0032105:Plasma [Body Substance]
   753   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "(39"

Phrase: ")."
Processing 00000000.tx.120: These studies indicate a critical and central role for A1-42 in amyloid plaque formation in AD. 

Phrase: "These studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "indicate"

Phrase: "a critical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511545:Critical [Qualitative Concept]

Phrase: "and"

Phrase: "central role for A1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in amyloid plaque formation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
   734   C0333463:amyloid plaque [Acquired Abnormality]
   734   C2936349:Plaque, Amyloid [Acquired Abnormality]

Phrase: "in AD."
Processing 00000000.tx.121: The findings presented here reveal a new aspect of A1-42 function, implying a role in inducing cholinergic dysfunction, besides amyloid plaque formation. 

Phrase: "The findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "here"

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "a new aspect of A1-42 function,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1547011:Aspect [Quantitative Concept]
   748   C1879746:Aspect [Qualitative Concept]

Phrase: "implying"

Phrase: "a role in inducing cholinergic dysfunction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "besides amyloid plaque formation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
   734   C0333463:amyloid plaque [Acquired Abnormality]
   734   C2936349:Plaque, Amyloid [Acquired Abnormality]
Processing 00000000.tx.122: In the present work, we used A1-42 freshly dissolved in water (non-aged A1-42), which exhibited no neurotoxicity and was confirmed to be in an oligomeric state by laser light-scattering analysis (data not shown). 

Phrase: "In the present work,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043227:Work [Occupational Activity]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "A1-42 freshly"

Phrase: "dissolved in water"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   790   C0599638:WATER [Substance]
   790   C1550678:Water [Inorganic Chemical]
   756   C1549535:Dissolve [Functional Concept]
   718 E C0443350:Watery [Qualitative Concept]

Phrase: "(non-aged A1-42"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0001779:Aged [Organism Attribute]
   812   C0001792:Aged [Population Group]
   812   C1518422:Non [Functional Concept]
   812   C1999167:aged [Population Group]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "no neurotoxicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0235032:Neurotoxicity [Injury or Poisoning]

Phrase: "and"

Phrase: "was"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be in an oligomeric state"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1301808:State [Geographic Area]
   760   C1442792:State [Functional Concept]
   760   C2987476:Be [Conceptual Entity]
   760   C3148680:State [Geographic Area]

Phrase: "by laser light-scattering analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.123: Therefore, the non-aged A1-42 used in our experiments probably does not form toxic amyloid fibrils, but does impair ACh synthesis in cholinergic neurons at very low concentrations (10-100 nM). 

Phrase: "Therefore,"

Phrase: "the non-aged A1-42"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0001779:Aged [Organism Attribute]
   812   C0001792:Aged [Population Group]
   812   C1518422:Non [Functional Concept]
   812   C1999167:aged [Population Group]

Phrase: "used in our experiments probably"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   760   C0681814:Experiments [Research Activity]
   760   C0750492:Probably [Idea or Concept]
   760   C1273517:used [Finding]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1706386:Experiment [Conceptual Entity]
   726 E C1947944:Use [Intellectual Product]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "toxic amyloid fibrils,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C1449651:Amyloid Fibrils [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0225328:fibrils [Cell Component]
   793 E C1948066:Fibril [Physical Object]

Phrase: "but"

Phrase: "does"

Phrase: "impair"

Phrase: "ACh synthesis in cholinergic neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1154432:acetylcholine synthesis [Molecular Function]
   760   C0220781:synthesis [Biologic Function]
   760   C1883254:Synthesis [Activity]

Phrase: "at very low concentrations"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]
   734   C0442811:Very low [Finding]

Phrase: "(10-100 nM)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]
Processing 00000000.tx.124: Soluble A1-42 production is uniquely elevated in brains of AD (2) and DS patients before amyloid plaque formation (36), suggesting a role of soluble A1-42 in the pathogenesis. 

Phrase: "Soluble A1-42 production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033268:production [Occupational Activity]

Phrase: "is"

Phrase: "uniquely"

Phrase: "elevated in brains of AD (2"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   767   C1310510:Brain-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0006104:Brains [Body Part, Organ, or Organ Component]
   753   C0205250:Elevated [Qualitative Concept]
   753   C3163633:Elevated [Qualitative Concept]
   719 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "and"

Phrase: "DS patients before amyloid plaque formation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0030705:Patients [Patient or Disabled Group]

Phrase: "(36"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a role of soluble A1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in the pathogenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0543483:pathogenesis [Functional Concept]
  1000   C0699748:Pathogenesis [Pathologic Function]
Processing 00000000.tx.125: We hypothesize that soluble A1-42 produced at an early stage of AD starts affecting cholinergic neurons by suppressing ACh synthesis, causes a reduction in ACh release, modulates synaptic connections, and finally results in cholinergic deficits, which may induce progressive loss of memory and cognitive function in AD patients. 

Phrase: "We"

Phrase: "hypothesize"

Phrase: "that soluble A1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1749467:soluble [Cell Component]
   827   C1948047:Soluble [Qualitative Concept]

Phrase: "produced at an early stage of AD starts"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C1517886:Early Stage [Classification]
   770   C2363430:Early stage [Temporal Concept]
   744   C0205390:Stage [Temporal Concept]
   744   C1279919:Early [Temporal Concept]
   744   C1300072:Stage [Clinical Attribute]
   744   C1306673:Stage [Qualitative Concept]
   711   C0439659:Start [Temporal Concept]

Phrase: "affecting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affecting [Functional Concept]
  1000   C1314939:Affecting [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "cholinergic neurons by suppressing ACh synthesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C2333949:Cholinergic Neurons [Cell]
   753   C0027882:Neurons [Cell]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a reduction in ACh release,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "synaptic connections,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449379:connections [Intellectual Product]

Phrase: "and"

Phrase: "finally"

Phrase: "results in cholinergic deficits,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0599668:cholinergic [Functional Concept]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]
   770   C2987487:deficits [Qualitative Concept]
   737 E C0162429:Deficit, NOS [Disease or Syndrome]

Phrase: "which"

Phrase: "may"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "progressive loss of memory"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   909   C0002622:Loss of memory [Mental or Behavioral Dysfunction]
           Memory loss
   909   C0751295:LOSS OF MEMORY [Sign or Symptom]
           Memory Loss
   770   C1517945:Loss [Quantitative Concept]

Phrase: "and"

Phrase: "cognitive function in AD patients."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0392335:cognitive function [Mental Process]
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1516691:Cognitive [Functional Concept]
   760   C1705273:Function [Intellectual Product]
Processing 00000000.tx.126: Thus, nontoxic, soluble A1-42 may play a primary role in the cholinergic dysfunction of AD patients by suppressing ACh synthesis, besides contributing to amyloid plaque formation. 

Phrase: "Thus,"

Phrase: "nontoxic,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518413:Nontoxic [Qualitative Concept]

Phrase: "soluble A1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1749467:soluble [Cell Component]
   827   C1948047:Soluble [Qualitative Concept]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a primary role in the cholinergic dysfunction of AD patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0035820:Role [Social Behavior]
   739   C1705810:Role [Conceptual Entity]

Phrase: "by suppressing ACh synthesis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1154432:acetylcholine synthesis [Molecular Function]
   827   C0220781:synthesis [Biologic Function]
   827   C1883254:Synthesis [Activity]

Phrase: "besides contributing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880177:Contributing [Activity]

Phrase: "to amyloid plaque formation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
   734   C0333463:amyloid plaque [Acquired Abnormality]
   734   C2936349:Plaque, Amyloid [Acquired Abnormality]
Processing 00000000.tx.127: TPKI/GSK-3 is present both in cytoplasm and in mitochondria in neurons (40). 

Phrase: "TPKI/GSK-3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0244989:GSK-3 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1325174:GSK [Molecular Function]

Phrase: "is"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "both in cytoplasm"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0010834:Cytoplasm [Cell Component]
   790   C0238767:Both [Spatial Concept]
   790   C1706086:Both [Qualitative Concept]
   718 E C0521449:Cytoplasmic [Body Location or Region]

Phrase: "and in mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026237:Mitochondria [Cell Component]
   790   C1515981:And [Idea or Concept]

Phrase: "in neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.128: We found that in cholinergic neurons non-aged A1-42 at 10nM activates mitochondrial TPKI/GSK-3, which mediates the reduction in ACh synthesis via PDH inactivation, as we had previously shown in hippocampal neurons (1). 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that in cholinergic neurons non-aged A1-42"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C2333949:Cholinergic Neurons [Cell]
   744   C0001779:Aged [Organism Attribute]
   744   C0001792:Aged [Population Group]
   744   C0027882:Neurons [Cell]
   744   C0599668:cholinergic [Functional Concept]
   744   C1518422:Non [Functional Concept]
   744   C1999167:aged [Population Group]

Phrase: "at 10nM"

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "mitochondrial TPKI/GSK-3,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0244989:GSK-3 [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0026237:Mitochondrial [Cell Component]
   812   C0521451:Mitochondrial [Functional Concept]
   812   C1325174:GSK [Molecular Function]

Phrase: "which"

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the reduction in ACh synthesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "via PDH inactivation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0544461:Inactivation [Cell or Molecular Dysfunction]
   734   C0034343:pyruvate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "as"

Phrase: "we"

Phrase: "had"

Phrase: "previously"

Phrase: "shown in hippocampal neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0019564:Hippocampal [Body Part, Organ, or Organ Component]
   770   C0027882:Neurons [Cell]
   737   C1547282:Show [Intellectual Product]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.129: One critical difference between the cholinergic and hippocampal systems lies in the energy metabolism. 

Phrase: "One critical difference between the cholinergic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "hippocampal systems"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   777 E C0205373:Systemic [Functional Concept]

Phrase: "lies in the energy metabolism."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0014272:Energy Metabolism [Physiologic Function]
   760   C0025519:Metabolism [Organism Function]
   760   C0025520:metabolism [Functional Concept]
   760   C0424589:Energy [Finding]
   760   C0542479:Energy [Natural Phenomenon or Process]
   760   C1442080:Energy [Quantitative Concept]
Processing 00000000.tx.130: In the case of hippocampal neurons, activation of mitochondrial TPKI/GSK-3 by aggregated A25-35 inactivates PDH, which causes the energy depletion (1). 

Phrase: "In the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of hippocampal neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "activation of mitochondrial TPKI/GSK-3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]

Phrase: "by aggregated A25-35"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0332621:Aggregated [Functional Concept]
   793 E C0205418:Aggregate [Qualitative Concept]

Phrase: "inactivates"

Phrase: "PDH,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0034343:pyruvate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0034354:pyruvate [Organic Chemical]
   861   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: "which"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "the energy depletion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333668:Depletion [Functional Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.131: Hippocampal neurons may die as a result of insufficient energy supply, as well as abnormally phosphorylated that impairs axonal transport (41). 

Phrase: "Hippocampal neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "may"

Phrase: "die as a result of insufficient energy supply,"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   770   C2945645:energy supply [Functional Concept]
   744   C0205412:Insufficient [Qualitative Concept]
   744   C0231180:Insufficient [Qualitative Concept]
   744   C0243163:supply [Idea or Concept]
   744   C0424589:Energy [Finding]
   744   C0542479:Energy [Natural Phenomenon or Process]
   744   C0699914:supply [Quantitative Concept]
   744   C1274040:Result [Functional Concept]
   744   C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
   744   C1442080:Energy [Quantitative Concept]
   744   C1546471:Result [Idea or Concept]
   744   C1561604:supply [Functional Concept]
   744   C1875802:SUPPLY [Medical Device]
   744   C1999230:Supply [Activity]
   744   C2825142:Result [Finding]

Phrase: "as well as"

Phrase: "abnormally"

Phrase: "phosphorylated"

Phrase: "that"

Phrase: "impairs"

Phrase: "axonal transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0004462:Axonal Transport [Cell Function]
   861   C0005528:Transport, NOS [Cell Function]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]
   789   C0004461:Axon [Cell Component]

Phrase: "(41"

Phrase: ")."
Processing 00000000.tx.132: However, in the case of cholinergic neurons, inactivation of PDH activity by non-aged A1-42 does not interfere with the energy metabolism and the neurons survive. 

Phrase: "However,"

Phrase: "in the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of cholinergic neurons,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C2333949:Cholinergic Neurons [Cell]
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "inactivation of PDH activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "by non-aged A1-42"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0001779:Aged [Organism Attribute]
   812   C0001792:Aged [Population Group]
   812   C1518422:Non [Functional Concept]
   812   C1999167:aged [Population Group]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "interfere with the energy metabolism"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0014272:Energy Metabolism [Physiologic Function]
   760   C0025519:Metabolism [Organism Function]
   760   C0025520:metabolism [Functional Concept]
   760   C0424589:Energy [Finding]
   760   C0521102:Interfere [Qualitative Concept]
   760   C0542479:Energy [Natural Phenomenon or Process]
   760   C1442080:Energy [Quantitative Concept]

Phrase: "and"

Phrase: "the neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "survive."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0310255:SURVIVE [Pharmacologic Substance]
Processing 00000000.tx.133: We speculate that the anaplerotic pathway between glycolytic breakdown and the tricarboxylic acid cycle functions in cholinergic neurons, but aggregated A inhibits this pathway in hippocampal neurons. 

Phrase: "We"

Phrase: "speculate"

Phrase: "that"

Phrase: "the anaplerotic pathway between glycolytic breakdown"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1704259:Pathway [Molecular Function]
   753   C1705987:Pathway [Conceptual Entity]
   748   C1512233:Glycolysis Pathway [Molecular Function]

Phrase: "and"

Phrase: "the tricarboxylic acid cycle"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0008858:Tricarboxylic Acid Cycle [Molecular Function]
   901   C0040887:tricarboxylic acid [Organic Chemical]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]
   827   C1511572:Cycle [Temporal Concept]

Phrase: "functions in cholinergic neurons,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C2333949:Cholinergic Neurons [Cell]
   770   C0027882:Neurons [Cell]
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0599668:cholinergic [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]

Phrase: "but"

Phrase: "aggregated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332621:Aggregated [Functional Concept]
   966 E C0205418:Aggregate [Qualitative Concept]

Phrase: "A"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "this pathway in hippocampal neurons."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1704259:Pathway [Molecular Function]
   760   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.134: Whether the difference in the energy metabolism depends on the A species or on the neuronal species needs to be clarified. 

Phrase: "Whether"

Phrase: "the difference in the energy metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "depends on the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0725813:depend [Medical Device]

Phrase: "A species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705920:Species [Conceptual Entity]

Phrase: "or on the neuronal species"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0521390:Neuronal [Immunologic Factor]
   760   C1705920:Species [Conceptual Entity]

Phrase: "needs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "clarified."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986669:Clarified [Activity]
Processing 00000000.tx.135: Based on the present study, we suggest that A1-42 participates directly in the induction of cholinergic deficiency, as well as amyloid plaque formation in AD. 

Phrase: "Based on the present study,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   760   C2603343:Study [Research Activity]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "we"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that A1-42"

Phrase: "participates"

Phrase: "directly in the induction of cholinergic deficiency,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0011155:Deficiency [Functional Concept]
   748   C0162429:Deficiency [Disease or Syndrome]
   748   C0205263:Induction [Functional Concept]
   748   C0599668:cholinergic [Functional Concept]
   748   C0857127:induction [Therapeutic or Preventive Procedure]
   748   C1623416:deficiency [Qualitative Concept]
   748   C1947931:Directly [Qualitative Concept]

Phrase: "as well as"

Phrase: "amyloid plaque formation in AD."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]
Processing 00000000.tx.136: Application of the findings presented here as a hypothetical in vitro model for AD pathogenesis should open up many possibilities for further research. 

Phrase: "Application of the findings"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0185125:Application [Health Care Activity]
   770   C1947919:Application [Intellectual Product]
   770   C2347934:Application [Intellectual Product]
   770   C3539080:APPLICATION [Quantitative Concept]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "here as a hypothetical in vitro model"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   814   C1515654:In Vitro Model [Research Activity]
   778   C0021135:In Vitro [Intellectual Product]
   778   C1533691:in vitro [Qualitative Concept]
           vitro
   778   C2827718:In Vitro [Functional Concept]
   748   C3161035:Model [Intellectual Product]

Phrase: "for AD pathogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0543483:pathogenesis [Functional Concept]
   861   C0699748:Pathogenesis [Pathologic Function]

Phrase: "should"

Phrase: "open up many possibilities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0175566:Open [Spatial Concept]

Phrase: "for further research."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
Processing 00000000.tx.137: FOOTNOTES * The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.138: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.139: Section 1734solely to indicate this fact.  

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.140: To whom correspondence may be addressed. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "may"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.141: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.142: 81-427-24-6313; 

Phrase: "81-427-24-6313"

Phrase: ";"
Processing 00000000.tx.143: Fax: 81-427-24-6316. 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "81-427-24-6316."
Processing 00000000.tx.144: 1 The abbreviations used are: AD, Alzheimer's disease; 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "AD,"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.145: ChAT, choline acetyltransferase; 

Phrase: "ChAT,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0008407:Choline Acetyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413376:CHOLINE ACETYLTRANSFERASE [Gene or Genome]
   861   C0001068:Acetyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0001390:Acetyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0008405:Choline [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "choline acetyltransferase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0008407:Choline Acetyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413376:CHOLINE ACETYLTRANSFERASE [Gene or Genome]
   861   C0001068:Acetyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0001390:Acetyltransferase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0008405:Choline [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.146: ACh, acetylcholine; 

Phrase: "ACh,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "acetylcholine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.147: AChE, acetylcholine esterase; 

Phrase: "AChE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001044:Acetylcholine esterase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   861   C0014894:Esterase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "acetylcholine esterase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001044:Acetylcholine esterase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   861   C0014894:Esterase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.148: A, amyloid peptide; 

Phrase: "A,"

Phrase: "amyloid peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.149: PDH, pyruvate dehydrogenase; 

Phrase: "PDH,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0034343:pyruvate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0034354:pyruvate [Organic Chemical]
   861   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: "pyruvate dehydrogenase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0034343:pyruvate dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0034354:pyruvate [Organic Chemical]
   861   C0244104:Pyruvate [Biologically Active Substance,Organic Chemical]

Phrase: ";"
Processing 00000000.tx.150: APP, amyloid precursor protein; 

Phrase: "APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.151: TPKI/GSK-3, protein kinase I/glycogen synthase kinase-3; 

Phrase: "TPKI/GSK-3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0244989:GSK-3 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1325174:GSK [Molecular Function]

Phrase: "protein kinase I/glycogen synthase kinase-3"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   877   C0244989:Glycogen Synthase Kinase 3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1515146:I 3 [Cell]
   845   C0206354:Glycogen Synthase Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   818   C0017932:Glycogen Synthase [Amino Acid, Peptide, or Protein,Enzyme]
   795   C0017911:Glycogen [Biologically Active Substance,Carbohydrate]
   795   C0132555:synthase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.152: DS, Down's syndrome; 

Phrase: "DS,"

Phrase: "Down's syndrome"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013080:Down Syndrome [Congenital Abnormality,Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: ";"
Processing 00000000.tx.153: FAD, familial AD; 

Phrase: "FAD,"

Phrase: "familial AD"

Phrase: ";"
Processing 00000000.tx.154: HPLC, high performance liquid chromatography. 

Phrase: "HPLC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008562:HPLC [Laboratory Procedure]

Phrase: "high performance liquid chromatography."
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
  1000   C0008562:Chromatography, High Performance Liquid [Laboratory Procedure]
  1000   C0687276:LIQUID CHROMATOGRAPHY, HIGH PERFORMANCE [Medical Device]
  1000   C1579831:High performance liquid chromatography [Functional Concept]
   861   C0008565:Liquid Chromatography [Laboratory Procedure]
   812   C0008550:Chromatography [Laboratory Procedure]
   812   C0205250:High [Qualitative Concept]
   812   C0302908:Liquid [Substance]
   812   C0597198:Performance [Individual Behavior]
   812   C1299351:High [Qualitative Concept]
   812   C1304698:Liquid [Finding]
   812   C1546699:Liquid NOS [Intellectual Product]
   812   C1561501:Liquid NOS [Substance]
   812   C1882330:Performance [Activity]
   812   C2700149:HIGH [Intellectual Product]
   712 E C0302647:chromatograph [Medical Device]
Processing 00000000.tx.155: Acknowledgment We thank Dr. 

Phrase: "Acknowledgment"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.156: Y.Kasai and R.

Phrase: "Y.Kasai"

Phrase: "and"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.157: Kuwahara (Mitsubishi Kasei Institute of Life Sciences) for their help with the HPLC electrochemical detection system and Dr. 

Phrase: "Kuwahara"

Phrase: "(Mitsubishi Kasei Institute of Life Sciences"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0021622:institute [Organization]
   753   C1272753:Institute [Idea or Concept]

Phrase: ")"

Phrase: "for their"

Phrase: "help with the HPLC electrochemical detection system"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0008562:HPLC [Laboratory Procedure]
   748   C0018896:Help [Social Behavior]
   748   C0449913:System [Functional Concept]
   748   C1511790:Detection [Therapeutic or Preventive Procedure]
   748   C1552861:help [Idea or Concept]
   748   C1553451:System [Manufactured Object]
   748   C1704459:System [Medical Device]

Phrase: "and"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.158: T.Hama (Mitsubishi Kasei Institute of Life Sciences) for her help with AChE staining. 

Phrase: "T.Hama (Mitsubishi Kasei Institute of Life Sciences"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0021622:institute [Organization]
   744   C1272753:Institute [Idea or Concept]

Phrase: ")"

Phrase: "for her"

Phrase: "help with AChE staining."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0001044:Acetylcholine esterase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0001041:Acetylcholine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   760   C0014894:Esterase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0018896:Help [Social Behavior]
   760   C0487602:Staining [Laboratory Procedure]
   760   C1552861:help [Idea or Concept]
   760   C1704680:Staining [Finding]
Processing 00000000.tx.159: REFERENCES Hoshi, M., Takashima, A., Noguchi, K., Murayama, M., Sato, M., Kondo, S., Saitoh, Y., Ishiguro, K., Hoshino, T., and Imahori, K. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Hoshi,"

Phrase: "M."

Phrase: ","

Phrase: "Takashima,"

Phrase: "A.,"

Phrase: "Noguchi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Murayama,"

Phrase: "M."

Phrase: ","

Phrase: "Sato,"

Phrase: "M."

Phrase: ","

Phrase: "Kondo,"

Phrase: "S."

Phrase: ","

Phrase: "Saitoh,"

Phrase: "Y.,"

Phrase: "Ishiguro,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hoshino,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Imahori,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.160: (1996) Proc. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.161: Natl. 

Phrase: "Natl."
Processing 00000000.tx.162: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.163: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.164: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.165: 93, 2719-2723 [Abstract/Free FullText] Kuo, Y.-M., Emmerling, M. 

Phrase: "93,"

Phrase: "2719-2723"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kuo,"

Phrase: "Y.-"

Phrase: "M."

Phrase: ","

Phrase: "Emmerling,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.166: R., Vigo-Pelfrey, C., Kasunic, T. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Vigo-Pelfrey,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Kasunic,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.167: C., Kirkpatrick, J. 

Phrase: "C., Kirkpatrick,"

Phrase: "J."
Processing 00000000.tx.168: B., Murdoch, G. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Murdoch,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.169: H., Ball, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ball,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706910:Ball [Manufactured Object]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.170: J., and Roher, A. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Roher,"

Phrase: "A."
Processing 00000000.tx.171: E. 

Phrase: "E."
Processing 00000000.tx.172: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.173: Biol. 

Phrase: "Biol."
Processing 00000000.tx.174: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.175: 271, 4077-4081 [Abstract/Free FullText] Davies, P., and Maloney, A. 

Phrase: "271,"

Phrase: "4077-4081"

Phrase: "[Abstract/Free FullText"

Phrase: "] Davies,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Maloney,"

Phrase: "A."
Processing 00000000.tx.176: J.F. 

Phrase: "J.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.177: (1976) Lancet 1976-2, 1403 Bowen, D. 

Phrase: "(1976"

Phrase: ")"

Phrase: "Lancet 1976-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0777169:Lancet [Medical Device]

Phrase: "1403 Bowen,"

Phrase: "D."
Processing 00000000.tx.178: M., Smith, C. 

Phrase: "M."

Phrase: ","

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "C."
Processing 00000000.tx.179: B., White, P., and Davison, A. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "White,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Davison,"

Phrase: "A."
Processing 00000000.tx.180: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.181: (1976) Brain 99, 459-496 [Medline] [OrderarticleviaInfotrieve] Perry, E. 

Phrase: "(1976"

Phrase: ")"

Phrase: "Brain 99,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "459-496"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Perry,"

Phrase: "E."
Processing 00000000.tx.182: K., Gibson, P. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Gibson,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.183: H., Blessed, G., Perry, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Blessed,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Perry,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.184: H., and Tomlinson, B. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Tomlinson,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.185: E. 

Phrase: "E."
Processing 00000000.tx.186: (1977) J. 

Phrase: "(1977"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.187: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.188: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.189: 34, 247-266 [CrossRef][Medline] [OrderarticleviaInfotrieve] Rossor, M. 

Phrase: "34,"

Phrase: "247-266"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Rossor,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.190: N., Garrett, N. 

Phrase: "N., Garrett,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.191: J., Johnson, A. 

Phrase: "J.,"

Phrase: "Johnson,"

Phrase: "A."
Processing 00000000.tx.192: L., Mountjoy, C. 

Phrase: "L., Mountjoy,"

Phrase: "C."
Processing 00000000.tx.193: Q., Roth, M., and Iversen, L. 

Phrase: "Q., Roth,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Iversen,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.194: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.195: (1982) Brain 105, 313-330 [Abstract] Wilcock, G. 

Phrase: "(1982"

Phrase: ")"

Phrase: "Brain 105,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "313-330"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Wilcock,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.196: K., Esiri, M. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Esiri,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.197: M., Bowen, D. 

Phrase: "M."

Phrase: ","

Phrase: "Bowen,"

Phrase: "D."
Processing 00000000.tx.198: M., and Smith, C. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "C."
Processing 00000000.tx.199: C.T. 

Phrase: "C.T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.200: (1982) J. 

Phrase: "(1982"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.201: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.202: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.203: 57, 407-417 [CrossRef][Medline] [OrderarticleviaInfotrieve] Whitehouse, P. 

Phrase: "57,"

Phrase: "407-417"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Whitehouse,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.204: J., Price, D. 

Phrase: "J.,"

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.205: L., Struble, R. 

Phrase: "L., Struble,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.206: G., Clark, A. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Clark,"

Phrase: "A."
Processing 00000000.tx.207: W., Coyle, J. 

Phrase: "W., Coyle,"

Phrase: "J."
Processing 00000000.tx.208: T., and DeLong, M. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "DeLong,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.209: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.210: (1982) Science 215, 1237-1239 [Medline] [OrderarticleviaInfotrieve] Bird, T. 

Phrase: "(1982"

Phrase: ")"

Phrase: "Science 215,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1237-1239"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.211: D., Stranaham, S., Sumi, S. 

Phrase: "D."

Phrase: ","

Phrase: "Stranaham,"

Phrase: "S."

Phrase: ","

Phrase: "Sumi,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.212: M., and Raskind, M. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Raskind,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.213: (1983) Ann. 

Phrase: "(1983"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.214: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.215: 14, 284-293 [Medline] [OrderarticleviaInfotrieve] Wood, P. 

Phrase: "14,"

Phrase: "284-293"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0043217:Wood [Substance]
   944 E C0144237:Sylvan [Organic Chemical]
   916 E C0442548:Woods [Geographic Area]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.216: L., Etienne, P., Lal, S., Nair, N. 

Phrase: "L., Etienne,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Lal,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416865:LAL [Gene or Genome]

Phrase: "S."

Phrase: ","

Phrase: "Nair,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.217: P.V., Finlayson, M. 

Phrase: "P.V., Finlayson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.218: H., Gauthier, S., Palo, J., Haltia, M., Paetau, A., and Bird, E. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Gauthier,"

Phrase: "S."

Phrase: ","

Phrase: "Palo,"

Phrase: "J.,"

Phrase: "Haltia,"

Phrase: "M."

Phrase: ","

Phrase: "Paetau,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "E."
Processing 00000000.tx.219: D. 

Phrase: "D."
Processing 00000000.tx.220: (1983) J. 

Phrase: "(1983"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.221: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.222: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.223: 62, 211-217 [CrossRef][Medline] [OrderarticleviaInfotrieve] Geula, C., and Mesulam, M.-M. 

Phrase: "62,"

Phrase: "211-217"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Geula,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Mesulam,"

Phrase: "M.-"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.224: (1996) Cerebral Cortex 6, 165-177 [Abstract] Selkoe, D. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Cerebral Cortex 6,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   827   C1176472:Cortex [Body Part, Organ, or Organ Component]
   827   C2700441:Cortex [Plant]

Phrase: "165-177"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Selkoe,"

Phrase: "D."
Processing 00000000.tx.225: J. 

Phrase: "J."
Processing 00000000.tx.226: (1991) Neuron 6, 487-498 [Medline] [OrderarticleviaInfotrieve] Perry, E. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Neuron 6,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "487-498"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Perry,"

Phrase: "E."
Processing 00000000.tx.227: K., Tomlinson, B. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tomlinson,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.228: E., Blessed, G., Bergmann, K., Gibson, P. 

Phrase: "E.,"

Phrase: "Blessed,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Bergmann,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Gibson,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.229: H., and Perry, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Perry,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.230: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.231: (1978) Br. 

Phrase: "(1978"

Phrase: ")"

Phrase: "Br."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704648:Br. [Conceptual Entity]
Processing 00000000.tx.232: Med. 

Phrase: "Med."
Processing 00000000.tx.233: J. 

Phrase: "J."
Processing 00000000.tx.234: 2, 1457-1459 [Medline] [OrderarticleviaInfotrieve] DeKosky, S. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "1457-1459"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] DeKosky,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.235: T., Harbaugh, R. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Harbaugh,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.236: E., Schmitt, F. 

Phrase: "E.,"

Phrase: "Schmitt,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.237: A., Bakay, R. 

Phrase: "A.,"

Phrase: "Bakay,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.238: A.E., Chui, H. 

Phrase: "A.E.,"

Phrase: "Chui,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.239: C., Knopman, D. 

Phrase: "C., Knopman,"

Phrase: "D."
Processing 00000000.tx.240: S., Reeder, T. 

Phrase: "S."

Phrase: ","

Phrase: "Reeder,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.241: M., Shetter, A. 

Phrase: "M."

Phrase: ","

Phrase: "Shetter,"

Phrase: "A."
Processing 00000000.tx.242: G., Senter, H. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Senter,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.243: J., and Markesbery, W. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Markesbery,"

Phrase: "W."
Processing 00000000.tx.244: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.245: (1992) Ann. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.246: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.247: 32, 625-632 [Medline] [OrderarticleviaInfotrieve] Lehricy, S., Hirsch, ., Cervera-Pirot, P., Hersh, L. 

Phrase: "32,"

Phrase: "625-632"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Lehricy,"

Phrase: "S."

Phrase: ","

Phrase: "Hirsch,"

Phrase: ".,"

Phrase: "Cervera-Pirot,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Hersh,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.248: B., Bakchine, S., Piette, F., Duyckaerts, C., Hauw, J.-J., Javoy-Agid, F., and Agid, Y. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Bakchine,"

Phrase: "S."

Phrase: ","

Phrase: "Piette,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Duyckaerts,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Hauw,"

Phrase: "J.-J.,"

Phrase: "Javoy-Agid,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Agid,"

Phrase: "Y."
Processing 00000000.tx.249: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.250: Comp. 

Phrase: "Comp."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0056167:COMP [Therapeutic or Preventive Procedure]
  1000   C1456376:COMP [Gene or Genome]
Processing 00000000.tx.251: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.252: 330, 15-31 [Medline] [OrderarticleviaInfotrieve] Bartus, R. 

Phrase: "330,"

Phrase: "15-31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Bartus,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.253: T., Dean III, R. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Dean III,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.254: L., Beer, B., and Lippa, A. 

Phrase: "L., Beer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0004922:Beer [Food]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Lippa,"

Phrase: "A."
Processing 00000000.tx.255: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.256: (1982) Science 217, 408-417 [Medline] [OrderarticleviaInfotrieve] Winkler, J., Suhr, S. 

Phrase: "(1982"

Phrase: ")"

Phrase: "Science 217,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "408-417"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Winkler,"

Phrase: "J.,"

Phrase: "Suhr,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.257: T., Gage, F. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Gage,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456564:Gauge [Spatial Concept]
  1000   C1521879:GAGE [Immunologic Factor]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.258: H., Thal, L. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Thal,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039736:THAL [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.259: J., and Fisher, L. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Fisher,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325045:Fisher [Mammal]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.260: J. 

Phrase: "J."
Processing 00000000.tx.261: (1995) Nature 375, 484-487 [CrossRef][Medline] [OrderarticleviaInfotrieve] Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schlossmacher, M., Whaley, J., Swindlehurst, C., McCormack, R., Wolfert, R., Selkoe, D., Lieberburg, I., and Schenk, D. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Nature 375,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "484-487"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Seubert,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Vigo-Pelfrey,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Esch,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Lee,"

Phrase: "M."

Phrase: ","

Phrase: "Dovey,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Davis,"

Phrase: "D."

Phrase: ","

Phrase: "Sinha,"

Phrase: "S."

Phrase: ","

Phrase: "Schlossmacher,"

Phrase: "M."

Phrase: ","

Phrase: "Whaley,"

Phrase: "J.,"

Phrase: "Swindlehurst,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "McCormack,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Wolfert,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Selkoe,"

Phrase: "D."

Phrase: ","

Phrase: "Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Schenk,"

Phrase: "D."
Processing 00000000.tx.262: (1992) Nature 359, 325-327 [CrossRef][Medline] [OrderarticleviaInfotrieve] Suzuki, N., Cheung, T. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Nature 359,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "325-327"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Cheung,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.263: T., Cai, X.-D., Odaka, A., Otvos, L., Jr., Eckman, C., Golde, T. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Cai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064494:CAI [Organic Chemical,Pharmacologic Substance]

Phrase: "X.-"

Phrase: "D."

Phrase: ","

Phrase: "Odaka,"

Phrase: "A.,"

Phrase: "Otvos,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Eckman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Golde,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.264: E., and Younkin, S. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.265: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.266: (1994) Science 264, 1336-1340 [Medline] [OrderarticleviaInfotrieve] Takashima, A., Noguchi, K., Sato, K., Hoshino, T., and Imahori, K. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Science 264,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1336-1340"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Takashima,"

Phrase: "A.,"

Phrase: "Noguchi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sato,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hoshino,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Imahori,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.267: (1993) Proc. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.268: Natl. 

Phrase: "Natl."
Processing 00000000.tx.269: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.270: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.271: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.272: 90, 7789-7793 [Abstract/Free FullText] Lorenzo, A., and Yankner, B. 

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "7789-7793"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lorenzo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1875453:LORENZO'S [Lipid,Pharmacologic Substance]

Phrase: "A.,"

Phrase: "and"

Phrase: "Yankner,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.273: A. 

Phrase: "A."
Processing 00000000.tx.274: (1994) Proc. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.275: Natl. 

Phrase: "Natl."
Processing 00000000.tx.276: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.277: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.278: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.279: 91, 12243-12247 [Abstract/Free FullText] Potter, P. 

Phrase: "91,"

Phrase: "12243-12247"

Phrase: "[Abstract/Free FullText"

Phrase: "] Potter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336168:potter [Professional or Occupational Group]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.280: E., Meek, J. 

Phrase: "E.,"

Phrase: "Meek,"

Phrase: "J."
Processing 00000000.tx.281: L., and Neff, N. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Neff,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.282: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.283: (1983) J. 

Phrase: "(1983"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.284: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.285: 41, 188-194 [Medline] [OrderarticleviaInfotrieve] Gibson, G. 

Phrase: "41,"

Phrase: "188-194"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Gibson,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.286: E., Jope, R., and Blass, J. 

Phrase: "E.,"

Phrase: "Jope,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Blass,"

Phrase: "J."
Processing 00000000.tx.287: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.288: (1975) Biochem. 

Phrase: "(1975"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.289: J. 

Phrase: "J."
Processing 00000000.tx.290: 148, 17-23 [Medline] [OrderarticleviaInfotrieve] Johnson, C. 

Phrase: "148,"

Phrase: "17-23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Johnson,"

Phrase: "C."
Processing 00000000.tx.291: D., and Russell, R. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Russell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979971:Russell [Laboratory Procedure]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.292: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.293: (1975) Anal. 

Phrase: "(1975"

Phrase: ")"

Phrase: "Anal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003461:Anal [Body Part, Organ, or Organ Component]
  1000   C2939124:Anal [Spatial Concept]
Processing 00000000.tx.294: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.295: 64, 229-238 [Medline] [OrderarticleviaInfotrieve] Marchbanks, R. 

Phrase: "64,"

Phrase: "229-238"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Marchbanks,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.296: M., Wonnacott, S., and Rubio, M. 

Phrase: "M."

Phrase: ","

Phrase: "Wonnacott,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Rubio,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.297: A. 

Phrase: "A."
Processing 00000000.tx.298: (1981) J. 

Phrase: "(1981"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.299: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.300: 36, 379-393 [Medline] [OrderarticleviaInfotrieve] Hefti, F., Hartikka, J., Eckenstein, F., Gnahn, H., Heumann, R., and Schwab, M. 

Phrase: "36,"

Phrase: "379-393"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hefti,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Hartikka,"

Phrase: "J.,"

Phrase: "Eckenstein,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Gnahn,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Heumann,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Schwab,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.301: (1985) Neuroscience 14, 55-68 [CrossRef][Medline] [OrderarticleviaInfotrieve] Pike, C. 

Phrase: "(1985"

Phrase: ")"

Phrase: "Neuroscience 14,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027910:Neuroscience [Biomedical Occupation or Discipline]
   861   C1552241:Neuroscience [Professional or Occupational Group]
   861   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "55-68"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450382:55 [Intellectual Product]
   861   C0450387:68 [Intellectual Product]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Pike,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014878:Pike [Fish]
  1000   C0522667:Pike [Manufactured Object]
  1000   C0730321:PIC [Disease or Syndrome]

Phrase: "C."
Processing 00000000.tx.302: J., Burdick, D., Walencewicz, A. 

Phrase: "J.,"

Phrase: "Burdick,"

Phrase: "D."

Phrase: ","

Phrase: "Walencewicz,"

Phrase: "A."
Processing 00000000.tx.303: J., Glabe, C. 

Phrase: "J.,"

Phrase: "Glabe,"

Phrase: "C."
Processing 00000000.tx.304: G., and Cotman, C. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Cotman,"

Phrase: "C."
Processing 00000000.tx.305: W. 

Phrase: "W."
Processing 00000000.tx.306: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.307: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.308: 13, 1676-1687 [Abstract] Hilbich, C., Kisters-Woike, B., Reed, J., Masters, C. 

Phrase: "13,"

Phrase: "1676-1687"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Hilbich,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Kisters-Woike,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Reed,"

Phrase: "J.,"

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.309: L., and Beyreuther, K. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Beyreuther,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.310: (1991) J. 

Phrase: "(1991"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.311: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.312: Biol. 

Phrase: "Biol."
Processing 00000000.tx.313: 218, 149-163 [Medline] [OrderarticleviaInfotrieve] Marchbanks, R. 

Phrase: "218,"

Phrase: "149-163"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Marchbanks,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.314: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.315: (1977) in Synapses (Cottrell, G. A., and Usherwood, P. N.R., eds), pp. 

Phrase: "(1977"

Phrase: ")"

Phrase: "in Synapses"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0039062:Synapses [Body Space or Junction]
   966 E C0598501:Synapsis [Cell Function]
   966 E C1633000:Synapsis [Plant]

Phrase: "(Cottrell,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "A.,"

Phrase: "and"

Phrase: "Usherwood,"

Phrase: "P. N.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "eds"

Phrase: ")"

Phrase: ","

Phrase: "pp."
Processing 00000000.tx.316: 81-101, Blackie, Glasgow Wurtman, R. 

Phrase: "81-101,"

Phrase: "Blackie,"

Phrase: "Glasgow Wurtman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.317: J. 

Phrase: "J."
Processing 00000000.tx.318: (1992) Trends Neurosci. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci."
Processing 00000000.tx.319: 15, 117-122 [CrossRef][Medline] [OrderarticleviaInfotrieve] Linn, T. 

Phrase: "15,"

Phrase: "117-122"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Linn,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.320: C., Pettit, F. 

Phrase: "C., Pettit,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.321: H., and Reed, L. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Reed,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.322: J. 

Phrase: "J."
Processing 00000000.tx.323: (1969) Proc. 

Phrase: "(1969"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.324: Natl. 

Phrase: "Natl."
Processing 00000000.tx.325: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.326: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.327: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.328: 62, 234-241 [Abstract] Popov, K. 

Phrase: "62,"

Phrase: "234-241"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Popov,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.329: M., Kedishvili, N. 

Phrase: "M."

Phrase: ","

Phrase: "Kedishvili,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.330: Y., Zhao, Y., Shimomura, Y., Crabb, D. 

Phrase: "Y.,"

Phrase: "Zhao,"

Phrase: "Y.,"

Phrase: "Shimomura,"

Phrase: "Y.,"

Phrase: "Crabb,"

Phrase: "D."
Processing 00000000.tx.331: W., and Harris, R. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Harris,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.332: A. 

Phrase: "A."
Processing 00000000.tx.333: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.334: Biol. 

Phrase: "Biol."
Processing 00000000.tx.335: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.336: 268, 26602-26606 [Abstract/Free FullText] Jarrett, J. 

Phrase: "268,"

Phrase: "26602-26606"

Phrase: "[Abstract/Free FullText"

Phrase: "] Jarrett,"

Phrase: "J."
Processing 00000000.tx.337: T., Berger, E. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Berger,"

Phrase: "E."
Processing 00000000.tx.338: P., and Lansbury, J. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Lansbury,"

Phrase: "J."
Processing 00000000.tx.339: P.T. 

Phrase: "P.T."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.340: (1993) Biochemistry 32, 4693-4697 [Medline] [OrderarticleviaInfotrieve] Gravina, S. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Biochemistry 32,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "4693-4697"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Gravina,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.341: A., Ho, L., Eckman, C. 

Phrase: "A.,"

Phrase: "Ho,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1832110:HO [Gene or Genome]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Eckman,"

Phrase: "C."
Processing 00000000.tx.342: B., Long, K. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Long,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205166:Long [Qualitative Concept]
  1000   C1706317:Long [Qualitative Concept]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.343: E., Otvos, J., L., Younkin, L. 

Phrase: "E.,"

Phrase: "Otvos,"

Phrase: "J.,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Younkin,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.344: H., Suzuki, N., and Younkin, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.345: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.346: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.347: Biol. 

Phrase: "Biol."
Processing 00000000.tx.348: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.349: 270, 7013-7016 [Abstract/Free FullText] Iwatsubo, T., Odaka, A., Suzuki, N., Mizusawa, H., Nukina, N., and Ihara, Y. 

Phrase: "270,"

Phrase: "7013-7016"

Phrase: "[Abstract/Free FullText"

Phrase: "] Iwatsubo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Odaka,"

Phrase: "A.,"

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Mizusawa,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nukina,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Ihara,"

Phrase: "Y."
Processing 00000000.tx.350: (1994) Neuron 13, 45-53 [Medline] [OrderarticleviaInfotrieve] Teller, J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Neuron 13,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "45-53"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Teller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551834:Teller [Population Group]

Phrase: "J."
Processing 00000000.tx.351: K., Russo, C., DeBusk, L. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Russo,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "DeBusk,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.352: M., Angelini, G., Zaccheo, D., Dagna-Bricarelli, F., Scartessini, P., Bertolini, S., Mann, D. 

Phrase: "M."

Phrase: ","

Phrase: "Angelini,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Zaccheo,"

Phrase: "D."

Phrase: ","

Phrase: "Dagna-Bricarelli,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Scartessini,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Bertolini,"

Phrase: "S."

Phrase: ","

Phrase: "Mann,"

Phrase: "D."
Processing 00000000.tx.353: M.A., Tabaton, M., and Gambetti, P. 

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Tabaton,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Gambetti,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.354: (1996) Nature Med. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Nature Med."
Processing 00000000.tx.355: 2, 93-95 [Medline] [OrderarticleviaInfotrieve] Sherrington, R., Rogaev, E. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "93-95"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Sherrington,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rogaev,"

Phrase: "E."
Processing 00000000.tx.356: I., Liang, Y., Rogaeva, E. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Liang,"

Phrase: "Y.,"

Phrase: "Rogaeva,"

Phrase: "E."
Processing 00000000.tx.357: A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., Tsuda, T., Mar, L., Foncin, J.-F., Bruni, A. 

Phrase: "A.,"

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "M."

Phrase: ","

Phrase: "Chi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1720589:Chi [Intellectual Product]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Holman,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tsuda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Mar"

Phrase: ","

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Foncin,"

Phrase: "J.-F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Bruni,"

Phrase: "A."
Processing 00000000.tx.358: C., Montesi, M. 

Phrase: "C., Montesi,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.359: P., Sorbi, S., Rainero, I., Pinessi, L., Nee, L., Chumakov, I., Pollen, D., Brookes, A., Sanseau, P., Polinsky, R. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Sorbi,"

Phrase: "S."

Phrase: ","

Phrase: "Rainero,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Pinessi,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Nee,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Chumakov,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Pollen,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032385:Pollen [Plant]
  1000   C0795585:POLLEN [Organic Chemical,Pharmacologic Substance]
  1000   C1320238:Pollen [Immunologic Factor]

Phrase: "D."

Phrase: ","

Phrase: "Brookes,"

Phrase: "A.,"

Phrase: "Sanseau,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Polinsky,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.360: J., Wasco, W., Da Silva, H. 

Phrase: "J.,"

Phrase: "Wasco,"

Phrase: "W.,"

Phrase: "Da Silva,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   789   C0144237:Silvan [Organic Chemical]
   768 E C0043217:Wood [Substance]
   768 E C0442548:Woods [Geographic Area]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.361: A.R., Haines, J. 

Phrase: "A.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Haines,"

Phrase: "J."
Processing 00000000.tx.362: L., Pericak-Vance, M. 

Phrase: "L., Pericak-Vance,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.363: A., Tanzi, R. 

Phrase: "A.,"

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.364: E., Roses, A. 

Phrase: "E.,"

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A."
Processing 00000000.tx.365: D., Fraser, P. 

Phrase: "D."

Phrase: ","

Phrase: "Fraser,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.366: E., Rommens, J. 

Phrase: "E.,"

Phrase: "Rommens,"

Phrase: "J."
Processing 00000000.tx.367: M., and St. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.368: George-Hyslop, P. 

Phrase: "George-Hyslop,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.369: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.370: (1995) Nature 375, 754-760 [CrossRef][Medline] [OrderarticleviaInfotrieve] Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Nature 375,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "754-760"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Levy-Lahad,"

Phrase: "E.,"

Phrase: "Wasco,"

Phrase: "W.,"

Phrase: "Poorkaj,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Romano,"

Phrase: "D."
Processing 00000000.tx.371: M., Oshima, J., Pettingell, W. 

Phrase: "M."

Phrase: ","

Phrase: "Oshima,"

Phrase: "J.,"

Phrase: "Pettingell,"

Phrase: "W."
Processing 00000000.tx.372: H., Yu, C.-E., Jondro, P. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "C.-E.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Jondro,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.373: D., Schmidt, S. 

Phrase: "D."

Phrase: ","

Phrase: "Schmidt,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.374: D., Wang, K., Crowley, A. 

Phrase: "D."

Phrase: ","

Phrase: "Wang,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Crowley,"

Phrase: "A."
Processing 00000000.tx.375: C., Fu, Y.-H., Guenette, S. 

Phrase: "C., Fu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0016360:FU [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   861   C1424823:FU [Gene or Genome]

Phrase: "Y.-H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Guenette,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.376: Y., Galas, D., Nemens, E., Wijsman, E. 

Phrase: "Y.,"

Phrase: "Galas,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0082651:gala [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966   C1439334:GALA [Gene or Genome]

Phrase: "D."

Phrase: ","

Phrase: "Nemens,"

Phrase: "E.,"

Phrase: "Wijsman,"

Phrase: "E."
Processing 00000000.tx.377: M., Bird, T. 

Phrase: "M."

Phrase: ","

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.378: D., Schellenberg, G. 

Phrase: "D."

Phrase: ","

Phrase: "Schellenberg,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.379: D., and Tanzi, R. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.380: E. 

Phrase: "E."
Processing 00000000.tx.381: (1995) Science 269, 973-977 [Medline] [OrderarticleviaInfotrieve] Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Science 269,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "973-977"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Scheuner,"

Phrase: "D."

Phrase: ","

Phrase: "Eckman,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Jensen,"

Phrase: "M."

Phrase: ","

Phrase: "Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "X.,"

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.382: D., Hardy, J., Hutton, M., Kukull, W., Larson, E., Levy-Lahad, E., Vitanen, M., Peskind, E., Poorkaj, P., Schellenberg, G., Tanzi, R., Wasco, W., Lannfelt, L., Selkoe, D., and Younkin, S. 

Phrase: "D."

Phrase: ","

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "Kukull,"

Phrase: "W.,"

Phrase: "Larson,"

Phrase: "E.,"

Phrase: "Levy-Lahad,"

Phrase: "E.,"

Phrase: "Vitanen,"

Phrase: "M."

Phrase: ","

Phrase: "Peskind,"

Phrase: "E.,"

Phrase: "Poorkaj,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Schellenberg,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Tanzi,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Wasco,"

Phrase: "W.,"

Phrase: "Lannfelt,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Selkoe,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.383: (1996) Nature Med. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Nature Med."
Processing 00000000.tx.384: 2, 864-870 [Medline] [OrderarticleviaInfotrieve] Hoshi, M., Sato, M., Kondo, S., Takashima, A., Noguchi, K., Takahashi, M., Ishiguro, K., and Imahori, K. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "864-870"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hoshi,"

Phrase: "M."

Phrase: ","

Phrase: "Sato,"

Phrase: "M."

Phrase: ","

Phrase: "Kondo,"

Phrase: "S."

Phrase: ","

Phrase: "Takashima,"

Phrase: "A.,"

Phrase: "Noguchi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Takahashi,"

Phrase: "M."

Phrase: ","

Phrase: "Ishiguro,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Imahori,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.385: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.386: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.387: (Tokyo) 118, 683-685 [Abstract] Takashima, A., Yamaguchi, H., Noguchi, K., Michel, G., Ishiguro, K., Sato, K., Hoshino, T., Hoshi, M., and Imahori, K. 

Phrase: "(Tokyo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: ")"

Phrase: "118,"

Phrase: "683-685"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Takashima,"

Phrase: "A.,"

Phrase: "Yamaguchi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Noguchi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Michel,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ishiguro,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sato,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hoshino,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hoshi,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Imahori,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.388: (1995) Neurosci. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Neurosci."
Processing 00000000.tx.389: Lett. 

Phrase: "Lett."
Processing 00000000.tx.390: 198, 83-86 [CrossRef][Medline] [OrderarticleviaInfotrieve] 1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "198,"

Phrase: "83-86"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 1997 by The American Society"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037455:society [Organization]
   760   C0596070:American [Population Group]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

